This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm of other and unspecified endocrine glands
CD2_BENIGN_ENDOCRINE_OTH_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna glandularum endocrinarum aliarum et non specificatarum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of other and unspecified endocrine glands
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of other and unspecified endocrine glands
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5100 | 3026 | 2074 |
| Unadjusted period prevalence (%) | 0.98 | 1.03 | 0.91 |
| Median age at first event (years) | 59.31 | 57.04 | 62.62 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4502
- Matched controls
- 45020
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
4503599627370496.0
323.0
2299
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
174.1
323.0
718
49
E22.1
ICD-10 Finland
Hyperprolactinaemia
60.0
323.0
395
72
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
3020.3
323.0
555
*
BC1AD
NOMESCO Finland
CT of adrenal glands
92.5
323.0
523
64
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
11007.9
323.0
1510
*
H02AB09
ATC
hydrocortisone; systemic
34.6
323.0
698
237
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
107.2
323.0
604
65
E23.00
ICD-10 Finland
Panhypopituitarism
179.6
320.1
333
20
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
1649.1
312.9
301
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
103.7
307.1
336
35
N04BC06
ATC
cabergoline; oral (dopamine agonists)
92.8
302.2
335
39
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
341.0
254.0
255
8
C61
ICD-10 Finland
Malignant neoplasm of prostate
428.7
246.5
245
6
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2377.0
245.9
236
*
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
114.5
229.8
249
23
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
182.9
217.1
226
13
130
Kela drug reimbursment
Malignant tumour
+∞
211.1
201
*
D35.31
ICD-10 Finland
Cyst in Rathke's pocket
+∞
210.0
200
*
115
Kela drug reimbursment
Breast cancer
+∞
205.8
196
*
H02AB02
ATC
dexamethasone; systemic
20.0
201.2
310
166
PJA12
NOMESCO Finland
Sentinel node biopsy
330.7
190.9
192
6
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
166.3
1429
6529
WF002
NOMESCO Finland
Radical radiotherapy
72.1
163.2
187
27
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
136.6
160.4
171
13
A04AA02
ATC
granisetron; systemic, transdermal
121.5
152.2
164
14
ZXC86
NOMESCO Finland
Use of endoscopic device
46.4
148.5
183
41
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
146.6
140
*
JN4BD
NOMESCO Finland
Extensive body CT
5.4
140.4
453
911
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
140.3
134
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
6.8
137.9
368
581
E26.0
ICD-10 Finland
Primary hyperaldosteronism
32.3
137.2
183
59
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
162.8
135.2
142
9
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
276.9
131.9
134
5
116
Kela drug reimbursment
Prostate cancer
+∞
130.8
125
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
91.0
126.9
141
16
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
77.8
126.1
143
19
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
13.6
121.8
217
167
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
117.2
112
*
102
Kela drug reimbursment
Diabetes insipidus
67.0
107.2
124
19
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
1062.9
106.8
104
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
106.2
1990
12605
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
9.1
106.0
231
265
A03FA01
ATC
metoclopramide; systemic, rectal
2.8
104.1
754
2984
H03AA01
ATC
levothyroxine sodium; systemic
2.3
103.3
1267
6663
G02CB01
ATC
bromocriptine; systemic
9.0
100.5
221
257
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.2
97.0
397
1011
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
+∞
96.2
92
*
HAC20
NOMESCO Finland
Total mastectomy
105.4
94.3
103
10
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
93.1
957
4582
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
885.4
89.0
87
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.2
89.0
361
910
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
187.7
88.6
92
5
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.0
88.0
581
2150
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
875.0
88.0
86
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.3
86.1
468
1509
N02BE01
ATC
paracetamol; systemic, rectal
2.2
85.7
3862
32870
WX402
NOMESCO Finland
General anaesthesia
2.5
85.5
760
3355
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
843.8
84.8
83
*
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
114.7
83.2
90
8
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.5
82.1
124
62
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
81.8
815
3813
WF003
NOMESCO Finland
Adjuvant radiotherapy
211.3
80.5
83
*
WZC30
NOMESCO Finland
Teaching
2.8
79.0
561
2165
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
97.4
78.2
86
9
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
8.0
78.1
183
236
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
77.0
870
4314
E23.05
ICD-10 Finland
Lack of TSH
40.9
76.3
96
24
D35.4
ICD-10 Finland
Benign neoplasm: Pineal gland
+∞
76.2
73
*
D35.30
ICD-10 Finland
Craniopharyngoma
+∞
76.2
73
*
H53.4
ICD-10 Finland
Visual field defects
6.3
75.7
210
346
G02CB03
ATC
cabergoline; oral (prolactine inhibitors)
26.8
75.5
105
40
L01BC06
ATC
capecitabine; oral
+∞
74.1
71
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
73.5
491
1819
L03AA13
ATC
pegfilgrastim; parenteral
729.8
73.4
72
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.7
72.9
219
399
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.2
72.7
294
736
JN4AD
NOMESCO Finland
Body CT examination
4.7
72.6
261
582
XCK00
NOMESCO Finland
Perimetry
3.1
72.3
434
1496
A02BC02
ATC
pantoprazole; systemic
1.8
71.9
2838
22060
E21.0
ICD-10 Finland
Primary hyperparathyroidism
7.7
71.3
172
232
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
71.3
1269
7577
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
68.7
1381
8590
B01AB05
ATC
enoxaparin; parenteral
1.9
68.4
1258
7580
BC4WT
NOMESCO Finland
Selective blood sample from adrenal gland with radiological guidance
146.3
68.1
72
5
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
68.1
1587
10377
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.3
67.2
187
309
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
66.8
2568
19577
L02BG04
ATC
letrozole; oral
8.7
65.9
146
172
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
65.8
63
*
C03DA01
ATC
spironolactone; oral
2.5
65.0
560
2403
BCA30
NOMESCO Finland
Unilateral adrenalectomy
118.5
65.0
70
6
D35.9
ICD-10 Finland
Benign neoplasm: Endocrine gland, unspecified
+∞
64.7
62
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
64.5
897
4828
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
63.7
61
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
167.3
63.1
66
*
J01DB01
ATC
cefalexin; oral
1.9
62.8
3600
30714
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
62.6
60
*
WX110
NOMESCO Finland
Local anesthesy
1.7
62.3
2958
23749
UJF32
NOMESCO Finland
Coloscopy
1.9
62.0
1145
6866
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
24.2
61.6
88
37
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
60.5
58
*
L02AE02
ATC
leuprorelin; implant, parenteral
10.7
60.3
119
114
L02BA01
ATC
tamoxifen; oral
44.2
59.9
74
17
D35.59
ICD-10 Finland
Other paragangliom
595.8
59.8
59
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
33.0
59.3
78
24
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
585.5
58.8
58
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.7
56.8
426
1684
2542
FHL
Transasal hypophysectomy
564.9
56.7
56
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.3
56.7
300
940
E24.8
ICD-10 Finland
Other Cushing syndrome
290.2
56.3
57
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
55.3
53
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
55.3
368
1352
ZX120
NOMESCO Finland
Intravenous
2.8
55.0
374
1393
A04AA55
ATC
palonosetron, combinations; systemic
+∞
53.2
51
*
E23.2
ICD-10 Finland
Diabetes insipidus
29.2
53.2
72
25
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
8.7
53.1
117
137
Y77
ICPC
Malignant neoplasm prostate
115.4
52.9
57
5
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
52.9
1037
6290
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.6
52.8
251
722
L02BB03
ATC
bicalutamide; oral
523.8
52.6
52
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
268.8
52.2
53
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
52.2
50
*
A04AA01
ATC
ondansetron; systemic, rectal
4.6
52.1
188
420
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.8
52.0
182
394
BC1BD
NOMESCO Finland
Extensive CT of adrenal glands
96.2
51.9
57
6
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
11.8
51.7
97
84
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
513.6
51.5
51
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
51.5
808
4516
H01CB03
ATC
lanreotide; parenteral
+∞
51.1
49
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
503.3
50.5
50
*
C08CA01
ATC
amlodipine; oral
1.7
50.4
1550
10766
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
50.3
1250
8158
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
50.1
48
*
H01AC01
ATC
somatropin; parenteral
81.1
50.0
56
7
ZXC95
NOMESCO Finland
Use of surgical navigator
8.2
49.6
113
140
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
7.9
49.6
116
150
N02AX02
ATC
tramadol; systemic, rectal
1.6
48.6
1779
12922
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.8
47.9
213
579
I15.2
ICD-10 Finland
Hypertension secondary to endocrine disorders
56.6
47.5
56
10
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.4
47.2
147
280
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
46.9
45
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
21.5
46.1
68
32
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
12.8
46.1
83
66
ZX080
NOMESCO Finland
Image guided radiotherapy
452.1
45.3
45
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
44.9
43
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
53.6
44.6
53
10
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
64.4
44.2
51
8
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.0
44.0
183
469
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
35.4
43.5
56
16
C50
ICD-10 Finland
Malignant neoplasm of breast
431.6
43.2
43
*
N02AA05
ATC
oxycodone; systemic
2.2
42.9
476
2290
AA1AD
NOMESCO Finland
CT of head and brain
1.7
42.9
1026
6561
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
42.8
41
*
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
421.4
42.2
42
*
C07AB07
ATC
bisoprolol; oral
1.5
42.0
1995
15275
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
216.9
41.9
43
*
UKC02
NOMESCO Finland
Cystoscopy
2.0
41.9
617
3341
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
148.0
41.8
44
*
HA1AA
NOMESCO Finland
X-ray mammography
3.6
41.8
195
553
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
41.7
40
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
41.5
525
2673
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
8.3
41.2
93
114
H01CB02
ATC
octreotide; parenteral
67.7
41.1
47
7
301
Kela drug reimbursment
Growth hormone
211.8
40.9
42
*
R51.80
ICD-10 Finland
Headache
1.9
40.8
648
3611
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
144.6
40.8
43
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
40.7
39
*
C03CA01
ATC
furosemide; systemic
1.7
40.1
1079
7123
BBA20
NOMESCO Finland
Exploration of parathyroid gland
19.3
40.0
61
32
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
40.0
389
1759
J01MA02
ATC
ciprofloxacin; systemic
1.6
40.0
1572
11460
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
39.6
38
*
B01AB10
ATC
tinzaparin; parenteral
3.0
39.6
243
841
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.8
39.6
174
469
A10BA02
ATC
metformin; oral
1.6
39.4
1184
8053
S18
ICPC
Laceration/cut
1.6
39.1
1666
12367
L03AA02
ATC
filgrastim; parenteral
29.2
38.6
52
18
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
38.6
37
*
D35.50
ICD-10 Finland
Carotid body
+∞
38.6
37
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
38.6
37
*
22620
ICD-8 Finland
Benign neoplasm of endocrine glands, Pituitary gland and craniopharyngeal duct (pouch)
+∞
38.6
37
*
JN4CD
NOMESCO Finland
Very extensive body CT
5.3
38.3
120
231
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
380.5
38.1
38
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
380.5
38.1
38
*
E260, I152
ICD-10 Finland
NA
84.8
37.8
42
5
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
37.5
36
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
37.5
36
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
6.2
37.3
103
170
KCD02
NOMESCO Finland
Transurethral resection of bladder
14.5
37.2
63
44
P01AB01
ATC
metronidazole; oral, rectal
1.5
36.9
1656
12396
9350/1-C75.2
ICD-O-3
Craniopharyngioma, NOS, of craniopharyngeal duct
+∞
36.5
35
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
35.8
368
1706
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
35.7
1662
12513
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
52.9
35.4
42
8
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.1
34.8
417
2070
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
95.8
34.7
38
*
J01MA12
ATC
levofloxacin; systemic
1.8
34.6
701
4224
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.1
34.6
426
2137
E23.03
ICD-10 Finland
Lack of ACTH
27.9
34.6
47
17
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
51.7
34.4
41
8
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
34.4
33
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
45.9
33.7
41
9
E23.6
ICD-10 Finland
Other disorders of pituitary gland
120.9
33.7
36
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
33.6
387
1888
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
50.4
33.5
40
8
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
31.7
33.5
44
14
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
33.4
32
*
X76
ICPC
Malignant neoplasm breast female
+∞
33.4
32
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
33.2
1032
7027
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
32.3
31
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
32.3
31
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
4.6
32.1
114
252
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
13.2
31.8
56
43
Z51.5
ICD-10 Finland
Palliative care
4.4
31.8
118
273
A04AD12
ATC
aprepitant; systemic
114.2
31.7
34
*
R4110
NOMESCO Finland
Physiotherapy
1.6
31.5
1013
6943
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
31.3
30
*
N03AX16
ATC
pregabalin; oral
1.6
31.2
963
6527
R06.0
ICD-10 Finland
Dyspnoea
1.6
31.0
1020
7025
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
314.9
30.9
31
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
314.9
30.9
31
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
13.7
30.7
53
39
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
7.6
30.7
73
98
G47.3
ICD-10 Finland
Sleep apnoea
1.6
30.4
917
6171
XKD00
NOMESCO Finland
Uroflowmetry
1.8
30.3
527
3011
T90
ICPC
Diabetes non-insulin dependent
1.6
30.3
963
6570
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
30.2
29
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
30.2
29
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
30.2
29
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.7
30.1
209
785
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
304.3
29.8
30
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.9
29.8
100
209
WF004
NOMESCO Finland
Palliative radiotherapy
156.0
29.7
31
*
WX882
NOMESCO Finland
High dependency care
3.7
29.4
133
369
2370A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Pituitary gland and craniopharyngeal duct
+∞
29.2
28
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
18.2
29.1
45
25
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
29.1
1079
7630
G02CB04
ATC
quinagolide; oral
57.0
29.1
34
6
H02AB06
ATC
prednisolone; systemic
1.4
29.0
1886
15019
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
28.9
312
1477
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
104.0
28.7
31
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
28.4
378
1954
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
48.9
28.4
34
7
R03AC02
ATC
salbutamol; inhalant
1.4
28.2
2160
17711
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
+∞
28.1
27
*
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
+∞
28.1
27
*
E66.8
ICD-10 Finland
Other obesity
2.4
28.0
254
1107
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
5.0
27.8
91
185
E22.9
ICD-10 Finland
Hyperfunction of pituitary gland, unspecified
283.1
27.8
28
*
CS494
NOMESCO Finland
Other visual field testing
3.5
27.7
132
382
SPAT1153
SPAT
Removal of sutures
1.5
27.7
1224
8988
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
27.6
2024
16436
XW000
NOMESCO Finland
Bone marrow biopsy
3.3
27.6
144
447
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
19.7
27.3
41
21
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
27.3
848
5730
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.7
27.1
633
3962
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
27.1
26
*
22680
ICD-8 Finland
Benign neoplasm of endocrine glands, Other specified endocrine glands
+∞
27.1
26
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
27.1
26
*
2271A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Parathyroid gland
+∞
27.1
26
*
E26.9
ICD-10 Finland
Hyperaldosteronism, unspecified
23.9
26.9
38
16
205
Kela drug reimbursment
Chronic hypertension
1.5
26.9
1108
8003
2522
FHL
Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)
75.6
26.8
30
*
R31
ICD-10 Finland
Unspecified haematuria
2.0
26.7
349
1788
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.0
26.6
109
278
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.8
26.5
89
187
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
26.4
404
2202
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
26.1
698
4531
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
4.8
26.1
89
190
D35.6
ICD-10 Finland
Benign neoplasm: Aortic body and other paraganglia
+∞
26.1
25
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
26.1
25
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
26.1
25
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
26.1
25
*
ZZR00
NOMESCO Finland
Flap of skin
8.1
26.0
59
74
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
25.9
968
6833
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
25.9
1499
11601
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.3
25.7
136
427
R50.9
ICD-10 Finland
Fever, unspecified
1.8
25.7
482
2816
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
262.0
25.7
26
*
L03AA14
ATC
lipegfilgrastim; parenteral
262.0
25.7
26
*
128
Kela drug reimbursment
Cancers of female genital organs
262.0
25.7
26
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
25.7
459
2640
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
135.7
25.6
27
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.7
25.4
183
702
ZXC96
NOMESCO Finland
Robot assisted procedure
7.5
25.3
60
81
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
25.0
24
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
9.2
24.9
52
57
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
24.9
628
4008
E87.6
ICD-10 Finland
Hypokalaemia
3.0
24.8
144
483
WW500
NOMESCO Finland
Blood transfusion
3.6
24.7
113
317
Z51.0
ICD-10 Finland
Radiotherapy session
251.5
24.7
25
*
E23
ICD-10 Finland
Hypofunction and other disorders of pituitary gland
251.5
24.7
25
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
9.1
24.7
52
58
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
130.7
24.6
26
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
130.7
24.6
26
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
24.5
426
2424
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
24.5
859
5962
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
24.5
565
3519
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
24.3
267
1270
105
Kela drug reimbursment
Adrenal cortical hypofunction
18.6
24.3
37
20
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
6.1
24.3
67
112
R03BB04
ATC
tiotropium bromide; inhalant
1.9
24.1
395
2206
E83.50
ICD-10 Finland
Hypercalcemia
5.5
24.1
72
133
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
24.1
1870
15210
J01FF01
ATC
clindamycin; systemic
1.5
24.0
1068
7809
E21.2
ICD-10 Finland
Other hyperparathyroidism
9.2
23.9
50
55
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.0
23.9
144
496
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
23.7
476
2838
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
23.6
839
5839
R42
ICD-10 Finland
Dizziness and giddiness
1.5
23.4
862
6041
SPAT1262
SPAT
Handing over of treatment supplies
1.6
23.4
711
4759
A02BC05
ATC
esomeprazole; systemic
1.4
23.4
1636
13039
A79
ICPC
Malignancy NOS
46.9
23.3
28
6
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
46.9
23.3
28
6
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.9
23.2
346
1866
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
5.3
23.2
71
135
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
23.1
649
4259
N06AX11
ATC
mirtazapine; oral
1.4
23.0
1247
9477
C74.1
ICD-10 Finland
Malignant neoplasm: Medulla of adrenal gland
+∞
22.9
22
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
22.9
22
*
2270A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Adrenal gland
+∞
22.9
22
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
22.9
22
*
SPAT1254
SPAT
Administration of medicine
1.7
22.8
550
3463
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
15.5
22.8
37
24
N06AX16
ATC
venlafaxine; oral
1.7
22.6
529
3302
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
8.5
22.5
49
58
H47.2
ICD-10 Finland
Optic atrophy
10.3
22.5
44
43
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.5
22.5
106
306
N07BA03
ATC
varenicline; oral
2.2
22.5
228
1050
A02BC01
ATC
omeprazole; systemic
1.5
22.4
1081
8019
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
22.3
811
5662
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
22.3
793
5508
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
22.2
487
2984
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
52.3
22.1
26
5
A10BH01
ATC
sitagliptin; oral
1.8
22.1
389
2225
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
22.0
329
1776
R5140
NOMESCO Finland
Monitoring the use of the aid
1.8
22.0
439
2613
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
21.9
21
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
21.9
21
*
Z31.5
ICD-10 Finland
Genetic counselling
2.7
21.9
158
608
R53
ICD-10 Finland
Malaise and fatigue
1.5
21.8
769
5329
C02AC05
ATC
moxonidine; oral
2.3
21.8
210
944
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
21.7
906
6514
ZX050
NOMESCO Finland
Stereotactic radiotherapy
22.3
21.7
31
14
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
21.6
294
1531
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
115.5
21.6
23
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
115.5
21.6
23
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
115.5
21.6
23
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.5
21.3
175
725
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
21.3
1644
13271
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
21.2
272
1386
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
33.9
21.1
27
8
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
33.9
21.1
27
8
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
21.0
380
2192
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
60.3
20.9
24
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
60.3
20.9
24
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
20.8
20
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
20.8
20
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
20.8
20
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
20.8
20
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
37.3
20.7
26
7
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
20.7
940
6872
25320
ICD-8 Finland
Diseases of pituitary gland, Chromophobe adenoma, pituitary
210.9
20.6
21
*
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
110.5
20.6
22
*
C08CA13
ATC
lercanidipine; oral
1.6
20.6
522
3329
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
3.1
20.5
112
362
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
20.4
600
3975
A06AD11
ATC
lactulose; oral
1.7
20.3
480
2999
N05CF01
ATC
zopiclone; oral
1.4
20.3
1213
9345
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.4
20.3
180
775
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
20.2
350
1988
S10
ICPC
Boil/carbuncle
2.1
20.1
223
1070
XJH00
NOMESCO Finland
Transanal ultrasonography
2.3
20.0
193
868
A11CC03
ATC
alfacalcidol; systemic
3.3
20.0
102
314
R60.0
ICD-10 Finland
Localized oedema
1.7
19.9
416
2512
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
19.8
19
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
19.8
19
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
19.8
19
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.0
19.6
260
1343
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
105.5
19.6
21
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
200.8
19.6
20
*
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
19.5
178
778
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
19.4
684
4727
C09CA01
ATC
losartan; oral
1.4
19.3
933
6890
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.4
19.3
93
274
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
19.3
278
1481
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.4
19.3
70
161
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
26.1
19.1
26
10
L02BG03
ATC
anastrozole; oral
20.1
19.0
28
14
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
19.0
398
2402
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.2
19.0
204
966
A28
ICPC
Limited function/disability NOS
1.6
19.0
507
3273
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
18.8
465
2942
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
18.8
18
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
18.8
18
*
BDA10
NOMESCO Finland
Operation on carotid body
+∞
18.8
18
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
18.8
18
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
18.8
18
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
27.9
18.7
25
9
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
18.5
234
1182
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
6.0
18.5
51
86
L02BG06
ATC
exemestane; oral
190.7
18.5
19
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.8
18.5
42
54
E66.00
ICD-10 Finland
Metabolic syndrome
2.0
18.3
241
1242
SPAT1263
SPAT
Sampling
1.3
18.2
1666
13716
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
44.2
18.2
22
5
Z71.8
ICD-10 Finland
Other specified counselling
1.4
18.2
890
6580
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.5
18.1
85
246
LCA06
NOMESCO Finland
Biopsy of endometrium
1.7
18.0
427
2669
T73
ICPC
Neoplasm endocrine other/unspecified
52.7
17.9
21
*
E23.08
ICD-10 Finland
Hypopituitarism
52.7
17.9
21
*
E23.7
ICD-10 Finland
Disorder of pituitary gland, unspecified
52.7
17.9
21
*
A02BA02
ATC
ranitidine; systemic
1.5
17.9
745
5330
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
17.9
188
878
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
17.8
1053
8058
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
22.8
17.7
25
11
1CD02
NOMESCO Finland
NA
+∞
17.7
17
*
8700/3-C74.9
ICD-O-3
Pheochromocytoma, NOS, of adrenal gland, NOS
+∞
17.7
17
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
17.7
17
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
17.7
17
*
ZXA10
NOMESCO Finland
Bilateral
1.5
17.5
689
4870
E23.0
ICD-10 Finland
Hypopituitarism
180.6
17.5
18
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
6.7
17.5
44
66
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.9
17.4
71
183
S77
ICPC
Malignant neoplasm of skin
28.9
17.4
23
8
TQW20
NOMESCO Finland
Tatoe
28.9
17.4
23
8
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
17.3
187
886
N06AX21
ATC
duloxetine; oral
1.7
17.3
419
2631
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
17.3
240
1262
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
42.1
17.3
21
5
A46
ICD-10 Finland
Erysipelas
1.6
17.2
507
3351
R4190
NOMESCO Finland
Nutritional therapy
2.9
17.2
105
366
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.6
17.2
60
133
N91.1
ICD-10 Finland
Secondary amenorrhoea
4.0
17.1
69
176
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
17.0
449
2887
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
17.0
528
3538
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
13.3
16.9
29
22
N03AX12
ATC
gabapentin; oral
1.5
16.9
608
4214
ZXA00
NOMESCO Finland
Right side
1.4
16.8
980
7472
C10AA01
ATC
simvastatin; oral
1.3
16.8
1684
14008
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
63.5
16.7
19
*
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
7.2
16.7
40
56
G44.2
ICD-10 Finland
Tension-type headache
1.6
16.7
507
3376
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
16.7
486
3204
L02BX02
ATC
degarelix; parenteral
+∞
16.7
16
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
16.7
16
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
16.7
16
*
L01AX03
ATC
temozolomide; systemic
+∞
16.7
16
*
N28.1
ICD-10 Finland
Cyst of kidney
4.0
16.7
66
166
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
16.6
2172
18754
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
16.5
480
3159
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
170.5
16.5
17
*
C90.0
ICD-10 Finland
Multiple myeloma
170.5
16.5
17
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
16.5
621
4344
KH1AD
NOMESCO Finland
CT of urinary organs
2.5
16.3
131
539
N05BA04
ATC
oxazepam; oral
1.4
16.3
913
6908
L28
ICPC
Limited function/disability (L)
1.5
16.2
558
3826
R11
ICD-10 Finland
Nausea and vomiting
1.8
16.1
273
1540
D01
ICPC
Abdominal pain/cramps general
1.7
16.1
386
2420
R10.0
ICD-10 Finland
Acute abdomen
2.5
16.0
126
514
106
Kela drug reimbursment
Hypoparathyroidism
10.8
15.9
30
28
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.6
15.8
439
2860
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
60.2
15.7
18
*
2520A
ICD-9 Finland
Disorders of parathyroid gland, Hyperparathyroidism
60.2
15.7
18
*
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
15.7
352
2164
WX892
NOMESCO Finland
Monitored bed care
1.8
15.7
265
1491
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.8
15.7
101
366
K02.1
ICD-10 Finland
Caries of dentine
1.3
15.6
2193
19053
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
15.6
15
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
15.6
15
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
15.6
15
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
15.6
15
*
N06AB04
ATC
citalopram; systemic
1.4
15.6
826
6179
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.9
15.6
216
1134
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
15.6
270
1535
121
Kela drug reimbursment
Severe hypofunction of sexual glands
3.1
15.6
87
288
2530A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Acromegaly and gigantism[ACROMEGALIA]
85.4
15.6
17
*
2533
FHL
Unilateral removal of additional egg
85.4
15.6
17
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.1
15.6
186
923
J01AA02
ATC
doxycycline; systemic
1.3
15.5
3227
29572
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
15.4
1459
11990
TQW99
NOMESCO Finland
Other minor procedure on skin
2.3
15.4
143
633
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
8.5
15.4
33
39
WX002
NOMESCO Finland
Sedation and analgesia
1.4
15.3
710
5183
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
15.3
444
2926
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
15.3
378
2391
WF099
NOMESCO Finland
Other radiotherapy
16.1
15.2
24
15
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
4.6
15.1
52
115
WX704
NOMESCO Finland
Intubation
1.8
15.0
246
1375
WX290
NOMESCO Finland
Other blockade of nerve
1.3
14.9
1618
13545
N06AB10
ATC
escitalopram; oral
1.4
14.8
724
5335
E21
ICD-10 Finland
Hyperparathyroidism and other disorders of parathyroid gland
16.5
14.7
23
14
ZX112
NOMESCO Finland
Subcutaneous
4.6
14.7
50
109
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.2
14.7
153
715
D352, E221
ICD-10 Finland
NA
+∞
14.6
14
*
V04CD01
ATC
metyrapone; oral
+∞
14.6
14
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
14.6
14
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
14.6
14
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
14.6
14
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
14.6
14
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
14.6
14
*
C09CA03
ATC
valsartan; oral
1.7
14.6
331
2043
J01DA01
ATC
[U] cefalexin; systemic
1.3
14.5
2485
22066
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
14.5
624
4483
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
14.5
1030
8090
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
150.4
14.5
15
*
AA4DM
NOMESCO Finland
Very extensive MRI examination of sella turcica with 3 Tesla magnet
150.4
14.5
15
*
A02BC03
ATC
lansoprazole; oral
1.3
14.5
1131
9016
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.9
14.5
201
1059
N04BC01
ATC
bromocriptine; oral
36.1
14.4
18
5
D06
ICPC
Abdominal pain localized other
1.7
14.4
301
1811
N06AA09
ATC
amitriptyline; systemic
1.6
14.4
397
2579
Y28
ICPC
Limited function/disability (Y)
8.9
14.4
30
34
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.1
14.4
77
248
ZXA05
NOMESCO Finland
Left side
1.4
14.3
903
6956
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
2.1
14.3
155
737
S29
ICPC
Skin symptom/complaint other
1.5
14.2
589
4196
JAH01
NOMESCO Finland
Laparoscopy
2.1
14.2
153
728
M79.6
ICD-10 Finland
Pain in limb
1.3
14.1
1369
11256
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
14.1
293
1760
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
14.0
1030
8126
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.6
13.9
63
179
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
13.9
164
808
RD211
NOMESCO Finland
NA
2.1
13.8
164
813
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
53.5
13.8
16
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
53.5
13.8
16
*
S06.0
ICD-10 Finland
Concussion
1.6
13.8
363
2332
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
2.2
13.8
145
682
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.2
13.8
73
234
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
10.4
13.7
26
25
C10AA05
ATC
atorvastatin; oral
1.3
13.7
1484
12383
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
13.7
570
4063
L72.1
ICD-10 Finland
Trichilemmal cyst
1.8
13.7
220
1222
-50
ICPC
Medication/prescr/renewal
2.1
13.6
157
767
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.9
13.6
81
282
BAA60
NOMESCO Finland
Total thyroidectomy
2.9
13.6
81
282
A12BA01
ATC
potassium chloride; oral
2.1
13.5
155
756
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
13.5
13
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
13.5
13
*
D35.3
ICD-10 Finland
Benign neoplasm: Craniopharyngeal duct
+∞
13.5
13
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
13.5
13
*
D35.7
ICD-10 Finland
Benign neoplasm: Other specified endocrine glands
+∞
13.5
13
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
13.5
13
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
13.5
13
*
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
13.5
13
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
13.5
13
*
B01AB04
ATC
dalteparin; parenteral
2.1
13.5
159
783
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
8.3
13.5
29
35
TAB00
NOMESCO Finland
Lumbar puncture
2.0
13.5
172
876
H47.4
ICD-10 Finland
Disorders of optic chiasm
140.4
13.4
14
*
2531A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]
140.4
13.4
14
*
XX1XN
NOMESCO Finland
Other isotope examination
140.4
13.4
14
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
8.8
13.4
28
32
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.1
13.4
147
703
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.0
13.4
78
266
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
13.4
293
1789
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
4.5
13.4
46
102
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
13.4
132
604
JN6AD
NOMESCO Finland
CT of torso and neck
7.7
13.3
30
39
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
21.2
13.3
19
9
H05BX01
ATC
cinacalcet; oral
6.2
13.3
35
57
H02AA02
ATC
fludrocortisone; oral
4.7
13.3
44
94
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
13.3
1149
9278
M54.5
ICD-10 Finland
Low back pain
1.3
13.2
1235
10088
N75
ICPC
Benign neoplasm nervous system
40.2
13.1
16
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
13.1
1540
12969
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
13.1
452
3097
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.0
13.1
75
252
J01FA10
ATC
azithromycin; systemic
1.3
13.1
2235
19722
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
13.1
263
1568
R02
ICPC
Shortness of breath/dyspnoea
1.5
13.0
441
3008
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
4.4
13.0
46
105
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.9
13.0
80
281
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.9
13.0
77
267
UDM02
NOMESCO Finland
Sinoscopy
2.6
13.0
93
361
XX9XW
NOMESCO Finland
NA
5.4
13.0
38
71
KAC10
NOMESCO Finland
Total nephrectomy with capsule
22.6
12.9
18
8
A04
ICPC
Weakness/tiredness general
1.5
12.9
436
2975
2159
FHL
Other measure in this category
50.1
12.8
15
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.6
12.8
363
2376
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
4.2
12.8
47
112
M04AA01
ATC
allopurinol; systemic
1.5
12.7
396
2653
G04CA02
ATC
tamsulosin; oral
1.4
12.6
680
5088
GDC00
NOMESCO Finland
Lobectomy of lung
15.4
12.6
20
13
C10AA07
ATC
rosuvastatin; oral
1.3
12.6
935
7373
N30.0
ICD-10 Finland
Acute cystitis
1.5
12.5
476
3327
RD210
NOMESCO Finland
NA
3.0
12.5
70
234
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
12.5
887
6941
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.2
12.5
123
561
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
12.5
12
*
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
12.5
12
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
12.5
12
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
12.5
12
*
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
+∞
12.5
12
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
12.5
12
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
12.5
12
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
12.5
12
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
12.5
12
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
12.5
12
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
12.5
12
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
12.5
12
*
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
7.3
12.4
29
40
2532A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Panhypopituitarism[PANHYPOPITUITARISMUS]
130.3
12.4
13
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
130.3
12.4
13
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
13.2
12.4
21
16
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.9
12.4
180
964
C07AA05
ATC
propranolol; systemic
1.4
12.3
702
5301
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.6
12.3
89
349
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
8.4
12.2
26
31
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
12.2
504
3582
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.8
12.2
220
1266
JFF23
NOMESCO Finland
Transversostomy
9.0
12.2
25
28
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
12.2
376
2511
A01
ICPC
Pain general/multiple sites
1.7
12.2
278
1720
C09AA02
ATC
enalapril; systemic
1.4
12.1
701
5306
321
Kela drug reimbursment
Paricalcitol and cinacalcet
5.8
12.0
33
57
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.7
12.0
273
1683
L02AE04
ATC
triptorelin; parenteral
21.3
12.0
17
8
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.6
12.0
342
2243
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
11.9
470
3310
D44.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified
46.8
11.9
14
*
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
2.1
11.8
131
634
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
11.8
726
5553
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.5
11.7
53
152
104
Kela drug reimbursment
Thyroid insufficiency
1.7
11.7
257
1573
XA800
NOMESCO Finland
Neuropsychological investigation
2.0
11.7
150
770
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
11.6
631
4719
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.8
11.6
73
263
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
11.6
168
900
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
4.3
11.6
42
99
N05AH04
ATC
quetiapine; oral
1.4
11.6
568
4174
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
11.6
237
1420
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
11.5
261
1610
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
9.2
11.5
23
25
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
11.5
11
*
L01CA04
ATC
vinorelbine; systemic
+∞
11.5
11
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
11.5
11
*
E89.39
ICD-10 Finland
Postprocedural hypopituitarism, other or several procedures
+∞
11.5
11
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
11.5
11
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
11.5
11
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
11.5
11
*
L04AX04
ATC
lenalidomide; oral
+∞
11.5
11
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
11.5
11
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
11.5
11
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
11.5
11
*
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
+∞
11.5
11
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
11.5
11
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
11.5
11
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
11.5
11
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
11.5
11
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
120.3
11.4
12
*
153
Kela drug reimbursment
Lenalidomid
120.3
11.4
12
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
120.3
11.4
12
*
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
2.0
11.4
148
764
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
5.0
11.3
35
70
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.6
11.3
301
1936
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.9
11.3
66
228
E27.9
ICD-10 Finland
Disorder of adrenal gland, unspecified
35.1
11.3
14
*
K30
ICD-10 Finland
Functional dyspepsia
1.5
11.2
382
2605
A08
ICPC
Swelling
2.0
11.2
140
711
E27.2
ICD-10 Finland
Addisonian crisis
17.1
11.2
17
10
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
11.2
889
7068
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.3
11.1
54
164
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.8
11.1
70
253
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
2.9
11.1
65
225
S21
ICPC
Skin texture symptom/complaint
1.5
11.1
406
2816
C03AA03
ATC
hydrochlorothiazide; oral
1.5
11.1
339
2260
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
4.1
11.1
42
104
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
11.0
2685
24458
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
11.0
1060
8649
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.8
11.0
69
249
J01CA04
ATC
amoxicillin; systemic
1.3
11.0
3244
30209
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
13.9
10.9
18
13
2397A
ICD-9 Finland
Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system
43.4
10.9
13
*
N20.1
ICD-10 Finland
Calculus of ureter
2.0
10.9
137
695
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.8
10.8
182
1027
C08CA02
ATC
felodipine; oral
1.5
10.8
327
2173
U05
ICPC
Urination problems other
1.9
10.7
155
832
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
9.6
10.7
21
22
KC1GB
NOMESCO Finland
Cystography with X-ray
17.8
10.7
16
9
T99
ICPC
Endocr/metab/nutrit disease other
2.7
10.7
71
264
XG466
NOMESCO Finland
Sleep oxymetry
2.0
10.7
127
633
A98
ICPC
Health maint/preventive medicine
1.5
10.6
4205
40723
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
60.1
10.6
12
*
K05.31
ICD-10 Finland
Periodontitis pronounced
1.5
10.6
354
2409
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
8.0
10.6
23
29
A55
ICPC
General and Unspecified, Local injection/infiltration
4.0
10.5
41
104
HAB99
NOMESCO Finland
Other partial excision of mammary gland
4.0
10.5
41
104
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
5.5
10.5
30
55
M03BX02
ATC
tizanidine; oral
1.2
10.5
2466
22313
R06AE07
ATC
cetirizine; oral
1.2
10.5
1601
13819
N05CF02
ATC
zolpidem; oral
1.4
10.5
622
4720
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
10.5
281
1813
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
10.5
490
3570
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.8
10.4
168
936
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.7
10.4
68
253
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
10.4
10
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
10.4
10
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
10.4
10
*
AA4AD
NOMESCO Finland
CT of sella turcica
+∞
10.4
10
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
10.4
10
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
10.4
10
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
10.4
10
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
10.4
10
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
10.4
10
*
D35.8
ICD-10 Finland
Benign neoplasm: Pluriglandular involvement
+∞
10.4
10
*
N20.0
ICD-10 Finland
Calculus of kidney
2.4
10.4
84
350
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
5.9
10.4
28
48
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.7
10.4
34
73
L57.0
ICD-10 Finland
Actinic keratosis
1.6
10.3
237
1470
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
12.0
10.3
18
15
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
32.6
10.3
13
*
BBA50
NOMESCO Finland
Total parathyroidectomy
32.6
10.3
13
*
Z00.0
ICD-10 Finland
General medical examination
1.4
10.3
654
5018
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
10.3
418
2962
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
18.8
10.2
15
8
E27.0
ICD-10 Finland
Other adrenocortical overactivity
18.8
10.2
15
8
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
10.2
1823
15994
M05BX04
ATC
denosumab; parenteral
2.0
10.2
135
702
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
23.4
10.2
14
6
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
10.2
364
2510
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
10.2
222
1357
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.4
10.2
83
349
SPAT1301
SPAT
No procedures
1.3
10.2
1154
9609
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.6
10.2
73
287
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.0
10.1
56
188
JAH00
NOMESCO Finland
Laparotomy
2.5
10.1
75
299
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.0
10.1
122
612
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
10.1
352
2416
E66.9
ICD-10 Finland
Obesity, unspecified
2.0
10.0
124
630
PJW99
NOMESCO Finland
Other operation on lymphatic system
40.1
10.0
12
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
40.1
10.0
12
*
C09DA01
ATC
losartan and diuretics; oral
1.5
9.9
372
2590
A10BJ02
ATC
liraglutide; parenteral
2.2
9.9
95
431
M01AB05
ATC
diclofenac; systemic, rectal
1.2
9.9
2661
24348
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.8
9.9
176
1011
D11
ICPC
Diarrhoea
1.5
9.9
357
2469
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.7
9.9
188
1104
ZX114
NOMESCO Finland
Intramuscular
3.1
9.8
51
164
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
26.1
9.8
13
5
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
2.0
9.8
118
592
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.2
9.7
94
429
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
9.7
1075
8910
M01AE02
ATC
naproxen; oral, rectal
1.2
9.7
2187
19629
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
9.7
401
2849
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
9.7
1510
13034
J01EA01
ATC
trimethoprim; systemic
1.3
9.7
869
7015
KAD00
NOMESCO Finland
Partial nephrectomy
13.4
9.7
16
12
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
55.1
9.6
11
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
55.1
9.6
11
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
55.1
9.6
11
*
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.3
9.6
84
365
K86.2
ICD-10 Finland
Cyst of pancreas
3.7
9.6
40
109
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
9.5
377
2657
A10AE04
ATC
insulin glargine; parenteral
1.5
9.5
317
2155
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
6.3
9.5
24
38
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.6
9.5
217
1344
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
3.5
9.5
43
125
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
5.2
9.5
28
54
A41.9
ICD-10 Finland
Sepsis, unspecified
2.1
9.5
102
488
G93.0
ICD-10 Finland
Cerebral cysts
6.0
9.5
25
42
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
4.6
9.5
31
67
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
9.5
677
5289
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
2.3
9.4
86
380
ZX095
NOMESCO Finland
Combined chemoradiotherapy
100.2
9.4
10
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
100.2
9.4
10
*
AA4BM
NOMESCO Finland
MRI examination of sella turcica with 3 Tesla magnet
100.2
9.4
10
*
D75
ICPC
Malignant neoplasm colon/rectum
30.1
9.4
12
*
A12AA04
ATC
calcium carbonate; oral
2.9
9.4
56
198
J01DA06
ATC
[U] cefuroxime; systemic
1.4
9.4
518
3882
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
9.4
9
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
9.4
9
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
9.4
9
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
9.4
9
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
9.4
9
*
L01CB01
ATC
etoposide; systemic
+∞
9.4
9
*
BC5AQ
NOMESCO Finland
Chromaffine tissue SPECT with low dose CT
+∞
9.4
9
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
9.4
9
*
8700/3-C74.1
ICD-O-3
Pheochromocytoma, NOS, of medulla of adrenal gland
+∞
9.4
9
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
9.4
9
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
9.4
9
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
9.4
9
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
9.4
9
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
12.3
9.3
16
13
ZZC00
NOMESCO Finland
Graft of fascia
12.3
9.3
16
13
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
21.7
9.3
13
6
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.4
9.3
43
127
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.0
9.3
121
626
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
9.3
483
3579
XG410
NOMESCO Finland
Flow-volume spirometry
1.8
9.3
143
786
A07AA02
ATC
nystatin; oral
1.7
9.3
200
1221
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
9.5
9.2
18
19
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
9.2
666
5209
PJA10
NOMESCO Finland
Exploration of lymph nodes
5.0
9.2
28
56
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
9.2
235
1502
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
3.2
9.2
47
150
C07AB02
ATC
metoprolol; systemic
1.3
9.2
720
5696
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
2.4
9.2
76
323
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.7
9.1
59
219
K92.1
ICD-10 Finland
Melaena
1.8
9.1
155
881
H02AB07
ATC
prednisone; oral
1.4
9.1
491
3663
N17
ICPC
Vertigo/dizziness
1.4
9.1
373
2647
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.5
9.1
41
119
207
Kela drug reimbursment
Chronic arrhythmias
1.4
9.1
467
3457
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
2.1
9.1
102
499
B01AA03
ATC
warfarin; systemic
1.3
9.1
640
4984
E83.51
ICD-10 Finland
Hypocalcemia
4.3
9.1
32
75
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.5
9.1
313
2146
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
11.5
9.0
16
14
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
5.9
9.0
24
41
E0000UV
ATC
NA
1.2
9.0
1403
12083
E27.8
ICD-10 Finland
Other specified disorders of adrenal gland
36.7
9.0
11
*
R51
ICD-10 Finland
Headache
1.7
9.0
175
1036
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.2
9.0
84
379
D02
ICPC
Abdominal pain epigastric
1.7
9.0
197
1206
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
4.4
9.0
31
71
Z72.0
ICD-10 Finland
Tobacco use
2.1
9.0
96
459
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.1
9.0
98
471
G04CA01
ATC
alfuzosin; oral
1.5
9.0
343
2402
M48.0
ICD-10 Finland
Spinal stenosis
1.4
8.9
433
3172
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
1.8
8.9
144
806
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
18.6
8.9
13
7
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
8.9
945
7782
ZXC50
NOMESCO Finland
Cryotherapy
2.5
8.9
68
277
D44.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Parathyroid gland
24.0
8.9
12
5
KEB00
NOMESCO Finland
Biopsy of prostate
5.2
8.9
26
50
A03
ICPC
Fever
1.4
8.9
495
3714
A10BH05
ATC
linagliptin; oral
1.8
8.9
158
912
L17
ICPC
Foot/toe symptom/complaint
1.3
8.9
901
7381
J02AC01
ATC
fluconazole; systemic
1.2
8.9
1466
12705
R52.9
ICD-10 Finland
Pain, unspecified
1.5
8.8
284
1915
SPAT1211
SPAT
Application of soft bandage
1.5
8.8
287
1942
JFB00
NOMESCO Finland
Partial resection of small intestine
3.3
8.8
43
133
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
4.0
8.8
33
82
C09CA06
ATC
candesartan; oral
1.3
8.8
770
6183
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
8.8
469
3496
E21.5
ICD-10 Finland
Disorder of parathyroid gland, unspecified
10.7
8.8
16
15
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.9
8.8
131
715
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
5.1
8.7
26
51
N06AB03
ATC
fluoxetine; oral
1.4
8.7
435
3201
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.7
8.7
165
970
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
3.3
8.7
41
124
G43.9
ICD-10 Finland
Migraine, unspecified
1.7
8.7
177
1063
DCB00
NOMESCO Finland
Excision of lesion of middle ear
50.1
8.7
10
*
M25.5
ICD-10 Finland
Pain in joint
1.3
8.7
1064
8913
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
8.7
393
2846
N20.9
ICD-10 Finland
Urinary calculus, unspecified
2.1
8.7
91
431
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.1
8.7
96
467
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
4.2
8.7
31
74
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.5
8.6
66
268
L03
ICPC
Low back symptom/complaint
1.3
8.6
861
7039
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
8.6
214
1358
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
8.6
471
3525
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
8.6
657
5178
J01FA06
ATC
roxithromycin; oral
1.2
8.6
1507
13136
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
2.7
8.5
56
211
R04.2
ICD-10 Finland
Haemoptysis
2.0
8.5
106
539
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.8
8.5
153
886
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
10.0
8.5
16
16
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
8.5
1499
13064
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
8.5
227
1468
C10AC01
ATC
colestyramine; oral
2.1
8.5
92
443
XX1AD
NOMESCO Finland
Other CT-examination
20.0
8.5
12
6
EBA00
NOMESCO Finland
Extraction of tooth
1.2
8.5
1161
9847
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.3
8.4
77
344
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
90.2
8.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
90.2
8.4
9
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
90.2
8.4
9
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
90.2
8.4
9
*
TKE10
NOMESCO Finland
Puncture of prostate
90.2
8.4
9
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
90.2
8.4
9
*
J01MA14
ATC
moxifloxacin; systemic
1.5
8.4
280
1904
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.1
8.4
90
434
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
8.4
2737
25320
R33
ICD-10 Finland
Retention of urine
1.6
8.4
213
1359
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
4.8
8.3
26
54
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
7.8
8.3
18
23
R20.2
ICD-10 Finland
Paraesthesia of skin
1.6
8.3
224
1451
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.3
8
*
C73.94
ICD-10 Finland
Medullary thyroid carcinoma (thyroid)
+∞
8.3
8
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
8.3
8
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
8.3
8
*
2550C
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING E HYPERSECRETIO HYPOFYSEOS]
+∞
8.3
8
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
8.3
8
*
8317/3-C64.9
ICD-O-3
Renal cell carcinoma, chromophobe type of kidney, NOS
+∞
8.3
8
*
E2300, D352
ICD-10 Finland
NA
+∞
8.3
8
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
8.3
8
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
8.3
8
*
8680/3-C75.5
ICD-O-3
Paraganglioma, NOS, of aortic body and other paraganglia
+∞
8.3
8
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
8.3
8
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
8.3
8
*
M14.5*E22.0
ICD-10 Finland
Arthropathy associated with acromegaly
+∞
8.3
8
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
8.3
8
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
8.3
8
*
D352, E220
ICD-10 Finland
NA
+∞
8.3
8
*
X77
ICPC
Malignant neopl genital female other
+∞
8.3
8
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
8.3
8
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
8.3
8
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
8.3
8
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
8.3
8
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
8.3
8
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
8.3
8
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
8.3
8
*
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
+∞
8.3
8
*
2549
FHL
NA
+∞
8.3
8
*
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.5
8.3
37
107
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
8.3
590
4596
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
6.2
8.3
21
34
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.8
8.3
145
832
M01AG02
ATC
tolfenamic acid; oral, rectal
1.3
8.3
539
4149
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
8.2
972
8103
G03HA01
ATC
cyproterone; systemic
7.1
8.2
19
27
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
1.8
8.2
128
707
K07
ICPC
Swollen ankles/oedema
1.8
8.2
143
822
-1
NOMESCO Finland
NA
1.2
8.2
1173
9991
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.6
8.2
56
214
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
8.2
1977
17755
C09BA02
ATC
enalapril and diuretics; systemic
1.5
8.2
283
1940
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
2.2
8.2
78
357
H53.2
ICD-10 Finland
Diplopia
1.9
8.1
106
552
T92
ICPC
Gout
2.5
8.1
63
259
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.9
8.1
118
639
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
5.4
8.1
23
43
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.6
8.1
214
1381
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.9
8.1
121
660
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
33.4
8.1
10
*
JLC10
NOMESCO Finland
Distal pancreatectomy
11.7
8.1
14
12
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
6.8
8.0
19
28
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.6
8.0
213
1375
KAT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of pelvis of kidney
3.1
8.0
41
132
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.8
8.0
132
743
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
3.5
8.0
35
100
U04
ICPC
Incontinence urine
1.7
8.0
147
859
C08CA05
ATC
nifedipine; systemic
1.6
8.0
211
1357
R86.9
ICD-10 Finland
Abnormal findings in specimens from male genital organs, unspecified abnormal finding
10.0
8.0
15
15
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
2.2
8.0
79
365
N01
ICPC
Headache
1.5
8.0
304
2126
X57
ICD-10 Finland
Unspecified privation
2.2
8.0
77
354
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
6.3
8.0
20
32
R01AD09
ATC
mometasone; nasal
1.2
8.0
1671
14790
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.5
8.0
301
2104
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.0
8.0
102
527
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
3.1
8.0
41
133
R01AD08
ATC
fluticasone; nasal
1.2
7.9
1016
8542
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
7.9
396
2916
R07.3
ICD-10 Finland
Other chest pain
1.4
7.9
324
2298
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.4
7.9
317
2238
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
7.9
1490
13045
160
Kela drug reimbursment
exenatide
2.2
7.9
79
369
M01AB55
ATC
diclofenac, combinations; oral
1.5
7.9
236
1568
J01MA06
ATC
norfloxacin; oral
1.4
7.9
466
3530
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
3.3
7.9
37
112
B02AA02
ATC
tranexamic acid; systemic
1.4
7.9
471
3574
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
7.8
577
4518
SPAT1234
SPAT
Support of social functional capacity
1.7
7.8
150
885
R03BA05
ATC
fluticasone; inhalant
1.3
7.8
626
4963
C07BB07
ATC
bisoprolol and thiazides; systemic
1.7
7.8
143
836
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
4.6
7.8
25
54
K59.09
ICD-10 Finland
Constipation, unspecified
1.6
7.8
185
1164
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.8
7.7
122
677
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.3
7.7
37
114
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.6
7.7
194
1237
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
4.4
7.7
26
59
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
45.0
7.7
9
*
E26
ICD-10 Finland
Hyperaldosteronism
45.0
7.7
9
*
E29.1
ICD-10 Finland
Testicular hypofunction
3.3
7.7
36
109
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.9
7.7
114
621
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
7.7
192
1224
R60.9
ICD-10 Finland
Oedema, unspecified
1.7
7.7
152
907
C09DA03
ATC
valsartan and diuretics; oral
1.7
7.7
164
1002
JFB30
NOMESCO Finland
Right hemicolectomy
4.6
7.7
25
55
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.1
7.6
39
126
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.5
7.6
54
214
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
7.6
3699
35404
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
25.0
7.6
10
*
KBE12
NOMESCO Finland
Transluminal endoscopic extraction of calculus of ureter
2.9
7.6
42
144
ZXC40
NOMESCO Finland
Use of ultrasound
4.5
7.5
25
56
R5110
SPAT
NA
2.1
7.5
83
404
TJF80
NOMESCO Finland
Ostomy education
6.1
7.5
19
31
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
7.5
745
6074
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.7
7.5
48
177
S15
ICPC
Foreign body in skin
1.6
7.5
190
1215
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
7.5
452
3436
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.4
7.5
60
254
R04.0
ICD-10 Finland
Epistaxis
1.5
7.5
216
1426
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.9
7.4
110
599
B01AF02
ATC
apixaban; oral
1.4
7.4
304
2160
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.2
7.4
71
327
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
3.7
7.4
30
81
R52.0
ICD-10 Finland
Acute pain
1.9
7.4
96
500
329
Kela drug reimbursment
Lenalidomide
80.2
7.4
8
*
G04BE30
ATC
drugs used in erectile dysfunction - combinations
80.2
7.4
8
*
AA4BD
NOMESCO Finland
Extensive CT of sella turcica
80.2
7.4
8
*
J20
ICD-10 Finland
Acute bronchitis
1.4
7.4
317
2270
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
13.4
7.4
12
9
C08CA10
ATC
nilvadipine; oral
2.1
7.4
77
366
S76
ICPC
Skin infection other
1.7
7.4
161
989
M79.1
ICD-10 Finland
Myalgia
1.4
7.4
428
3233
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
7.4
113
623
SPAT1255
SPAT
Intravenous administration of medicine
1.6
7.3
202
1317
SPAT1240
SPAT
Therapeutic discussion
1.4
7.3
331
2396
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.7
7.3
23
49
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
7.3
7
*
H01AX01
ATC
pegvisomant; parenteral
+∞
7.3
7
*
L02BB04
ATC
enzalutamide; oral
+∞
7.3
7
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
7.3
7
*
25300
ICD-8 Finland
Diseases of pituitary gland, Aeromegalia
+∞
7.3
7
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
7.3
7
*
L02BX03
ATC
abiraterone; oral
+∞
7.3
7
*
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
7.3
7
*
C75.0
ICD-10 Finland
Malignant neoplasm: Parathyroid gland
+∞
7.3
7
*
BCA41
NOMESCO Finland
Endoscopic bilateral adrenalectomy
+∞
7.3
7
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
7.3
7
*
E24.1
ICD-10 Finland
Nelson syndrome
+∞
7.3
7
*
1501
Kela drug reimbursment
Palbociclib
+∞
7.3
7
*
E22
ICD-10 Finland
Hyperfunction of pituitary gland
+∞
7.3
7
*
C16.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of stomach
+∞
7.3
7
*
8510/3-C73.9
ICD-O-3
Medullary carcinoma, NOS, of thyroid gland
+∞
7.3
7
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
7.3
7
*
JN7AN
NOMESCO Finland
Somatostatin receptor isotope imaging
+∞
7.3
7
*
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
+∞
7.3
7
*
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
+∞
7.3
7
*
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
7.3
7
*
9350/1-C75.1
ICD-O-3
Craniopharyngioma, NOS, of pituitary gland
+∞
7.3
7
*
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
+∞
7.3
7
*
394
Kela drug reimbursment
Palbociclib
+∞
7.3
7
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
7.3
7
*
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.9
7.3
103
554
E22.2
ICD-10 Finland
Syndrome of inappropriate secretion of antidiuretic hormone
10.9
7.3
13
12
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
6.8
7.3
17
25
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
9.4
7.3
14
15
L86
ICPC
Back syndrome with radiating pain
1.6
7.3
192
1241
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.4
7.2
312
2237
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.2
7.2
66
296
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
15.7
7.2
11
7
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
15.7
7.2
11
7
M02AA07
ATC
piroxicam; topical
1.2
7.2
1329
11593
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
2.9
7.2
42
148
N03AX09
ATC
lamotrigine; oral
1.7
7.2
151
920
A09AA02
ATC
multienzymes (lipase, protease etc.)
2.5
7.2
54
221
R52.2
ICD-10 Finland
Other chronic pain
1.8
7.2
108
595
SPAT1216
SPAT
Assessment of functional ability
1.3
7.2
501
3897
WZA90
NOMESCO Finland
Other doctors statement
1.3
7.1
787
6496
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
7.1
404
3039
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
30.0
7.1
9
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
30.0
7.1
9
*
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
7.1
604
4822
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.1
7.1
74
354
R13
ICD-10 Finland
Dysphagia
1.5
7.1
203
1335
BB1BN
NOMESCO Finland
Parathyroid gland isotope imaging, 2 isotopes
20.0
7.1
10
5
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
7.1
355
2618
R55
ICD-10 Finland
Syncope and collapse
1.4
7.1
348
2556
M01AH05
ATC
etoricoxib; oral
1.2
7.1
2279
20898
H05.2
ICD-10 Finland
Exophthalmic conditions
6.0
7.1
18
30
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
6.0
7.1
18
30
G03DB01
ATC
dydrogesterone; oral
1.3
7.0
436
3328
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.3
7.0
59
254
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.7
7.0
139
830
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
2.5
7.0
51
206
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.7
7.0
141
849
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.4
7.0
57
244
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
7.0
2153
19664
J01FA09
ATC
clarithromycin; systemic
1.2
6.9
1139
9814
N64.3
ICD-10 Finland
Galactorrhoea not associated with childbirth
5.4
6.9
19
35
R95
ICPC
Chron obstructive pulmonary disease
2.0
6.9
85
435
S97
ICPC
Chronic ulcer skin
1.6
6.8
159
994
RS221
NOMESCO Finland
NA
2.6
6.8
48
188
S04
ICPC
Lump/swelling localized
1.4
6.8
279
1980
N62
ICD-10 Finland
Hypertrophy of breast
1.7
6.8
127
747
H01
ICPC
Ear pain/earache
1.4
6.8
340
2503
DFF00
NOMESCO Finland
Pure tone audiometry
1.4
6.8
301
2171
A10BX07
ATC
[U] liraglutide; parenteral
2.4
6.8
52
215
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.6
6.8
159
998
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.7
6.8
147
901
A10BK03
ATC
empagliflozin; oral
1.5
6.8
239
1647
N03AX14
ATC
levetiracetam; systemic
2.0
6.8
80
402
SPAT1229
SPAT
Assessment of need for aid
1.5
6.8
249
1733
H93.1
ICD-10 Finland
Tinnitus
1.5
6.8
220
1494
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
6.1
6.8
17
28
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
40.1
6.8
8
*
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
40.1
6.8
8
*
2535A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Diabetes insipidus
40.1
6.8
8
*
H35.20
ICD-10 Finland
Proliferative vitreoretinopathy
40.1
6.8
8
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
40.1
6.8
8
*
N03AX11
ATC
topiramate; oral
1.9
6.7
88
459
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
16.7
6.7
10
6
R01AD12
ATC
fluticasone furoate; nasal
1.2
6.7
1022
8736
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
6.7
2417
22327
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.5
6.7
241
1671
C09DA06
ATC
candesartan and diuretics; oral
1.5
6.7
245
1701
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
2.8
6.7
40
144
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
4.3
6.7
23
54
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
6.7
487
3808
JMA10
NOMESCO Finland
Transabdominal total splenectomy
7.2
6.7
15
21
JF2BD
NOMESCO Finland
Extensive colon CT
3.0
6.7
36
122
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
4.1
6.7
24
59
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
3.2
6.7
32
100
SPAT1097
SPAT
Recording of ECG
1.3
6.7
516
4071
L12
ICPC
Hand/finger symptom/complaint
1.3
6.7
460
3569
162
Kela drug reimbursment
liraglutide
2.5
6.6
48
194
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
2.9
6.6
36
123
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.5
6.6
251
1759
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.5
6.6
47
187
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
7.8
6.6
14
18
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
4.2
6.6
23
55
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.1
6.6
69
330
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.0
6.6
81
416
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
12.2
6.6
11
9
XF402
NOMESCO Finland
ECG with work load test
1.3
6.6
390
2959
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
2.4
6.6
50
206
M01AH03
ATC
valdecoxib; oral
1.5
6.5
223
1529
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
1.7
6.5
117
680
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
6.5
1022
8756
U14
ICPC
Kidney symptom/complaint
2.5
6.5
47
189
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.1
6.5
66
310
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.0
6.5
76
382
R03BA02
ATC
budesonide; inhalant
1.3
6.5
597
4817
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.8
6.5
111
635
M10.9
ICD-10 Finland
Gout, unspecified
1.5
6.5
191
1267
KDE20
NOMESCO Finland
Removal of foreign body from urethra
5.0
6.5
19
38
C07AB03
ATC
atenolol; systemic
1.5
6.5
188
1245
JEA01
NOMESCO Finland
Laparoscopic appendectomy
1.7
6.5
113
654
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.9
6.5
24
61
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
3.8
6.4
25
66
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
69.9
6.4
7
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
69.9
6.4
7
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
69.9
6.4
7
*
JLC00
NOMESCO Finland
Excision of lesion of pancreas
69.9
6.4
7
*
XQ848
NOMESCO Finland
Dermatological photography
2.1
6.4
66
316
KE1BG
NOMESCO Finland
MRI of prostate
7.4
6.4
14
19
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.0
6.4
33
109
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.4
6.4
49
204
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
3.6
6.4
26
72
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
2.6
6.4
43
168
D09
ICPC
Nausea
1.7
6.3
119
704
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.6
6.3
168
1088
N06AB06
ATC
sertraline; oral
1.4
6.3
346
2589
JFB46
NOMESCO Finland
Resection of sigmoid colon
3.0
6.3
33
110
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.9
6.3
89
481
D12
ICPC
Constipation
1.8
6.3
102
575
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
6.3
76
386
N63
ICD-10 Finland
Unspecified lump in breast
1.6
6.3
142
886
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
18.0
6.3
9
5
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.4
6.3
274
1973
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.5
6.3
228
1586
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
2.8
6.2
37
133
U77
ICPC
Malignant neopl urinary tract other
+∞
6.2
6
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
6.2
6
*
E220, D352
ICD-10 Finland
NA
+∞
6.2
6
*
E22.80
ICD-10 Finland
Central precocious puberty
+∞
6.2
6
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
+∞
6.2
6
*
D44.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Craniopharyngeal duct
+∞
6.2
6
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
6.2
6
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
6.2
6
*
2550X
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING NUD]
+∞
6.2
6
*
E22.88
ICD-10 Finland
Other hyperfunction of pituitary gland
+∞
6.2
6
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
6.2
6
*
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
+∞
6.2
6
*
D350, E260
ICD-10 Finland
NA
+∞
6.2
6
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
6.2
6
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
6.2
6
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
6.2
6
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
6.2
6
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
+∞
6.2
6
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
6.2
6
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
6.2
6
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
6.2
6
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
6.2
6
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
6.2
6
*
2550A
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SDR CUSHING E HYPERPLASIA GLANDULAE SUPRARENALI]
+∞
6.2
6
*
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
+∞
6.2
6
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
6.2
6
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
6.2
6
*
C43.61
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna
+∞
6.2
6
*
C54.1
ICD-10 Finland
Malignant neoplasm: Endometrium
+∞
6.2
6
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
6.2
6
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.2
6
*
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
6.2
6
*
E260, D350
ICD-10 Finland
NA
+∞
6.2
6
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
6.2
6
*
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
6.2
6
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
6.2
6
*
WW402
NOMESCO Finland
Leucoferesis
+∞
6.2
6
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
6.2
6
*
P03
ICPC
Feeling depressed
1.4
6.2
260
1856
G04BE09
ATC
vardenafil; oral
26.7
6.2
8
*
N76
ICPC
Neoplasm nervous system unspecified
26.7
6.2
8
*
25200
ICD-8 Finland
Diseases of parathyroid gland, Hyperparathyroidism
26.7
6.2
8
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.3
6.2
392
3002
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
4.3
6.2
21
49
N06AX12
ATC
bupropion; oral
1.5
6.2
182
1208
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
4.8
6.2
19
40
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.5
6.2
174
1143
ZXF05
NOMESCO Finland
Interruption of procedure for other patient related reason
4.1
6.2
22
54
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
3.1
6.2
31
101
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
3.1
6.2
31
101
Z00.8
ICD-10 Finland
Other general examinations
1.5
6.2
214
1476
A06AH03
ATC
naloxegol; oral
5.7
6.1
16
28
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.6
6.1
132
810
K61.0
ICD-10 Finland
Anal abscess
2.4
6.1
48
203
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
7.7
6.1
13
17
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
7.7
6.1
13
17
L14
ICPC
Leg/thigh symptom/complaint
1.4
6.1
233
1638
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.6
6.1
145
917
PC5DE
NOMESCO Finland
Ultrasound of kidney circulation with Doppler technic
4.6
6.1
19
41
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
4.6
6.1
19
41
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
2.2
6.1
58
267
5702
FHL
Local lymph node removal (eg armpit, groin)
12.5
6.1
10
8
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
12.5
6.1
10
8
N05BA01
ATC
diazepam; systemic, rectal
1.3
6.1
439
3432
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.2
6.1
56
256
KAE12
NOMESCO Finland
Retrograde ureteronephroscopic lithotripsy in pelvis of kidney
3.8
6.1
23
60
A10BJ06
ATC
semaglutide; parenteral
1.7
6.1
113
669
SPAT1260
SPAT
Consultation of another employee
1.3
6.0
606
4943
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
1.9
6.0
81
431
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
1.9
6.0
76
394
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(37021550) Renin [Units/volume] in Plasma --upright
209
68
32.01
322.03
1.3
1.3
mu/l
62.5
71.0
0.14
156
47
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
397
415
10.29
307.65
3.8
1.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
1132
482
29.90
307.65
1.5
1.2
nmol/l
0.2
0.3
1.02
88
30
(3021387) Prolactin [Units/volume] in Serum or Plasma
1242
1146
14.00
307.65
4.4
1.4
mu/l
377.4
302.8
2.31
1208
1025
(43055514) Macroprolactin [Presence] in Serum or Plasma
241
67
37.70
307.65
1.9
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
971
2429
4.70
307.65
4.3
2.2
nmol/l
11.7
14.1
15.31
900
2146
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
1039
224
58.00
307.65
3.1
1.6
nmol/l
17.1
19.0
2.17
1024
205
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
1128
473
30.34
307.65
1.5
1.3
nmol/l
0.6
3.9
0.69
1102
453
(3011985) Renin [Units/volume] in Plasma
988
473
25.67
307.65
1.5
1.4
mu/l
59.2
63.3
0.14
927
414
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
928
450
24.99
307.65
1.4
1.3
pmol/l
256.1
302.6
2.16
806
329
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
213
49
45.32
307.65
2.3
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
228
73
32.65
307.65
1.3
1.1
pmol/l
272.9
283.6
0.07
166
47
(3009214) Lutropin [Units/volume] in Serum or Plasma
680
872
8.84
307.65
1.9
1.3
u/l
7.8
10.2
3.62
565
710
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
452
92
53.81
307.65
3.8
1.4
ug/l
1.0
1.0
0.01
437
84
(3035637) Corticotropin [Mass/volume] in Plasma
729
314
26.92
307.65
2.1
1.3
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
523
149
39.00
307.65
2.0
1.6
nmol/l
4.2
3.2
0.39
452
115
(3036481) Cortisol [Moles/volume] in Serum or Plasma
2561
3364
14.28
307.65
4.0
1.7
nmol/l
302.7
371.7
30.31
2425
3051
(4035726)
812
1261
7.47
307.65
1.3
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
1011
416
30.06
307.65
1.5
1.2
nmol/l
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
285
146
20.62
307.65
1.2
1.4
umol/l
2.6
4.5
7.85
263
138
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
1038
426
30.34
307.65
1.5
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
285
215
13.98
304.65
3.6
1.6
nmol/l
5.0
3.6
0.69
277
205
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3309
19471
2.99
299.11
9.0
5.6
mmol/l
1.2
1.2
0.08
2872
16401
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2979
17510
2.69
253.18
7.4
5.2
mmol/l
1.2
1.2
0.11
2800
15585
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3112
19200
2.59
231.00
6.3
3.8
umol/l
10.6
11.5
3.85
2979
17964
(3013826) Glucose [Moles/volume] in Serum or Plasma
3543
23673
2.63
215.60
6.0
4.2
mmol/l
6.8
6.7
0.35
3401
21952
(3024561) Albumin [Mass/volume] in Serum or Plasma
2721
16260
2.44
208.69
5.6
3.9
g/l
35.2
36.0
11.00
2581
14923
(3018418) pH of Serum or Plasma
2063
11326
2.38
185.75
4.8
3.3
ph
7.4
7.4
0.87
418
1993
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
662
2014
3.63
181.90
3.6
1.5
ug/l
31.6
10.2
0.79
542
1486
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4135
30973
2.77
179.36
8.8
5.5
u/l
79.3
75.2
5.79
3979
28734
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
204
207
10.22
179.31
1.4
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2756
17485
2.25
171.72
4.6
3.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
2022
11300
2.31
171.42
2.7
2.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
3235
22148
2.26
163.98
8.9
6.7
e9/l
4.4
4.2
5.38
2854
19059
(3023323) Follitropin [Units/volume] in Serum or Plasma
558
1625
3.73
162.98
1.8
1.3
iu/l
22.5
30.5
6.42
460
1416
(3032080) INR in Blood by Coagulation assay
2526
15692
2.21
162.94
9.1
9.1
inr
1.2
1.3
1.84
787
4523
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
700
2409
3.21
157.00
3.2
3.0
pmol/l
4.4
4.5
3.28
641
2125
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
993
4147
2.73
156.77
6.9
7.2
kpa
5.2
5.1
4.67
959
3951
(3027801) Oxygen [Partial pressure] in Arterial blood
991
4145
2.73
155.91
6.9
7.2
kpa
13.2
11.8
10.67
953
3944
(3003396) Base excess in Arterial blood by calculation
986
4117
2.73
155.62
6.9
7.2
mmol/l
1.1
1.2
0.51
773
3163
(40768804) Tissue Pathology biopsy report
2331
14283
2.16
152.65
2.3
1.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1035
4518
2.62
148.85
6.3
6.6
mmol/l
104.6
104.3
0.84
1014
4418
(3033923) Metanephrine [Moles/time] in 24 hour Urine
130
90
14.80
145.27
1.2
1.1
umol/24h
0.8
0.7
0.34
57
41
(3023368) Bacteria identified in Blood by Culture
1721
9509
2.22
144.68
4.5
3.8
—
—
—
0
0
(3002256) Pathology report gross observation
854
3453
2.77
142.52
1.3
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1057
4765
2.54
141.48
6.2
5.6
mmol/l
1.0
1.0
1.87
995
4401
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
253
436
6.05
140.68
1.9
1.4
nmol/l
0.3
0.4
0.56
182
359
(3033658) Prothrombin time (PT) actual/Normal
1700
9506
2.18
137.29
4.1
3.5
%
93.1
90.1
4.93
1650
9241
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
548
1786
3.32
133.56
6.8
9.7
mmol/l
24.2
24.3
0.52
527
1644
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4196
33254
2.48
133.52
5.9
3.9
pmol/l
14.8
14.8
1.27
3974
30310
(3026782) Osmolality of Urine
1385
7276
2.24
129.41
3.0
2.6
mosm/kgh2o
536.8
545.6
0.73
1217
6068
(3008295) Osmolality of Serum or Plasma
220
365
6.25
127.03
2.1
1.4
mosm/kgh2o
283.2
278.4
1.85
198
277
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1553
8619
2.15
125.82
2.7
2.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1145
5645
2.33
123.85
3.4
2.6
mmol/l
0.8
0.8
1.42
1081
5212
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
315
798
4.14
111.05
2.8
1.9
pmol/l
176.1
201.5
3.38
299
754
(3002582) Erythrocytes [#/volume] in Urine
1873
11555
1.98
110.73
3.7
3.0
e6/l
140.6
71.3
0.56
1482
8681
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
381
1111
3.63
109.92
2.6
1.8
nmol/l
41.7
41.9
0.04
374
1065
(3006504) Eosinophils/100 leukocytes in Blood
2685
18720
1.92
109.72
6.4
5.7
%
2.7
3.0
6.38
2539
17260
(3022096) Basophils/100 leukocytes in Blood
2618
18124
1.91
109.10
6.4
5.8
%
0.7
0.7
2.23
2469
16725
(3019069) Monocytes/100 leukocytes in Blood
2691
18827
1.91
108.26
6.7
6.0
%
8.4
8.6
1.30
2545
17461
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1982
12620
1.93
105.50
2.9
2.3
u/l
59.2
58.4
0.17
1855
11599
(3016502) Oxygen saturation in Arterial blood
819
3723
2.43
104.98
7.6
7.6
%
95.9
95.4
1.57
795
3574
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
709
3031
2.56
103.65
4.8
3.8
ng/l
97.8
91.7
0.79
630
2580
(3002030) Lymphocytes/100 leukocytes in Blood
2722
19327
1.88
102.38
6.5
5.8
%
27.2
28.4
6.78
2571
17820
(3006315) Basophils [#/volume] in Blood
2823
20301
1.87
101.73
6.0
5.6
e9/l
0.0
0.0
0.93
2450
17475
(3013115) Eosinophils [#/volume] in Blood
2896
21039
1.87
100.57
6.2
5.7
e9/l
0.2
0.2
1.38
2557
18416
(3001604) Monocytes [#/volume] in Blood
2803
20192
1.86
99.60
5.9
5.6
e9/l
0.6
0.6
4.52
2426
17387
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2498
17387
1.86
98.81
2.9
2.2
nmol/l
76.1
78.0
2.95
2307
15529
(3018095) Leukocytes [#/volume] in Urine
2100
13847
1.88
98.62
4.3
3.4
e6/l
124.4
97.9
0.42
1557
9507
(3019198) Lymphocytes [#/volume] in Blood
2858
20768
1.86
98.19
6.0
5.6
e9/l
1.9
1.9
0.96
2530
18217
(3002173) Hemoglobin [Mass/volume] in Arterial blood
752
3397
2.42
97.24
8.0
8.0
g/l
123.8
123.2
0.33
724
3261
(3030467) Casts [#/volume] in Urine by Automated count
1719
10679
1.92
96.57
3.5
2.9
e6/l
0.4
0.4
0.15
1326
7886
(3018010) Neutrophils/100 leukocytes in Blood
2679
19158
1.84
96.12
6.3
5.6
%
58.3
57.0
6.62
2539
17751
(3031040) Bacteria [#/volume] in Urine by Automated count
3461
26823
1.90
95.77
5.4
4.2
e6/l
1258.3
1667.8
0.22
49
348
(42870588) Differential panel, method unspecified - Blood
2019
13252
1.87
95.32
6.1
5.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1906
12511
1.84
88.20
3.5
2.0
mmol/l
2.4
2.4
2.66
1679
10551
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
659
2928
2.44
87.87
2.3
2.1
g/l
0.2
0.2
1.94
620
2665
(3000991) Gas panel - Venous blood
661
2954
2.42
86.96
8.1
8.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
967
5076
2.12
86.18
2.8
2.6
%
21.0
23.3
5.25
842
4289
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1017
5503
2.06
83.27
2.7
2.5
g/l
2.4
2.3
0.18
949
5075
(36304419) Bacteria [Presence] in Urine
1641
10428
1.85
83.27
3.5
2.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
741
3547
2.27
82.98
3.8
2.9
u/l
230.3
234.2
0.40
691
3297
(3019550) Sodium [Moles/volume] in Serum or Plasma
4879
43924
3.56
82.20
24.5
14.0
mmol/l
139.7
139.8
0.90
4845
42781
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4561
39718
2.40
82.03
6.3
4.7
mu/l
1.7
2.0
5.06
4264
36475
(3021589) Normoblasts [#/volume] in Blood
2495
18009
1.75
81.67
11.1
8.3
e9/l
0.0
0.0
0.47
2083
14678
(3013707) Erythrocyte sedimentation rate by Westergren method
3857
31632
1.90
81.42
4.8
4.1
mm/h
13.4
11.4
13.17
3640
29303
(3023103) Potassium [Moles/volume] in Serum or Plasma
4882
44062
3.53
79.94
24.7
14.1
mmol/l
3.9
4.0
9.72
4840
42837
(3000850) Epithelial cells [#/volume] in Urine
1342
8096
1.89
79.62
3.0
2.4
e6/l
6.0
5.4
0.84
1188
6986
(3026008) Bacteria identified in Urine by Culture
1784
11766
1.79
79.19
3.5
3.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1073
6024
1.99
78.77
2.8
2.5
umol/l
12.3
13.5
6.35
1012
5553
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1561
9962
1.82
76.88
2.6
2.2
mg/l
3.0
2.9
2.49
1385
8487
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4738
42217
2.72
76.83
19.7
11.9
mg/l
23.3
22.1
1.79
4129
32466
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1043
5870
1.98
75.68
2.0
2.0
s
29.6
29.8
0.41
1010
5683
(3037467) Urinalysis macro (dipstick) panel - Urine
3532
28573
1.77
73.23
5.1
4.1
—
—
—
0
0
(3036603) Volume of Urine
133
231
5.88
73.16
1.5
1.4
ml
1721.1
2009.9
0.57
14
50
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1898
13025
1.73
71.53
3.1
2.7
u/l
35.1
33.7
0.19
1811
12300
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
452
1862
2.57
70.21
9.0
10.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4538
40072
2.20
68.17
19.0
10.8
ml/min/173m2
80.8
80.7
0.20
4052
32288
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
502
2206
2.41
67.80
7.8
9.4
%
0.7
0.7
0.24
502
2188
(3014007) Fractional oxyhemoglobin in Arterial blood
503
2220
2.40
67.26
7.8
9.4
%
94.1
93.6
1.15
503
2212
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1024
5935
1.91
67.19
2.0
1.7
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
502
2221
2.40
66.74
7.8
9.3
%
1.4
1.4
0.18
502
2205
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1015
5899
1.90
65.90
3.1
2.7
e6/l
2.9
2.7
0.13
571
3097
(3020779) Urea [Moles/volume] in Serum or Plasma
646
3209
2.16
65.04
7.9
7.6
mmol/l
9.8
10.1
0.68
615
3051
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
58
41
14.30
63.87
1.2
1.1
umol/24h
2.1
1.7
1.63
58
41
(40758558) Short blood count panel - Blood
1434
9367
1.74
62.76
6.6
4.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
774
4174
2.01
62.34
2.6
2.3
umol/l
6.7
7.5
0.43
657
3577
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2367
17665
1.63
62.01
3.4
2.8
ug/l
130.8
116.1
1.64
2201
16326
(3014111) Lactate [Moles/volume] in Serum or Plasma
629
3170
2.12
60.79
6.9
6.9
mmol/l
1.2
1.4
3.44
604
3061
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1862
13133
1.66
60.70
2.3
2.1
u/l
185.2
223.1
1.05
1768
12267
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
55
39
14.25
60.45
5.7
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
237
759
3.23
58.52
3.3
2.0
u/ml
228.5
95.1
0.44
199
617
(3010370) Gastrin [Moles/volume] in Serum or Plasma
53
38
14.08
57.88
3.1
1.5
pmol/l
47.2
28.6
0.86
47
32
(3042936) Bacteria identified in Isolate by Culture
895
5249
1.86
55.50
2.2
2.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
112
217
5.25
54.77
1.2
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
208
642
3.34
54.52
1.6
1.3
mmol/l
73.1
63.8
1.85
183
521
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
591
3090
2.03
51.29
4.0
3.0
mmol/l
1.2
1.2
0.17
547
2615
(3020564) Creatinine [Moles/volume] in Serum or Plasma
4888
45419
2.83
51.19
24.5
13.6
umol/l
79.8
76.7
5.47
4888
45404
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
646
3499
1.97
50.69
2.6
2.2
u/l
31.7
51.0
0.79
574
2962
(3027945) Reticulocytes/100 erythrocytes in Blood
728
4112
1.90
50.39
2.9
2.2
%
1.8
1.8
1.69
648
3582
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1039
6563
1.73
49.53
2.9
2.5
e6/l
1.1
1.2
0.17
597
3737
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3325
27708
1.57
49.27
3.7
2.9
u/l
54.2
44.4
6.76
3143
25706
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1220
8068
1.67
48.98
4.1
3.7
ng/l
300.2
455.4
0.58
929
6189
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
501
2507
2.11
48.85
1.6
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
580
3068
2.00
48.60
2.4
1.6
g/l
66.0
67.0
2.44
527
2744
(3021447) Carbon dioxide [Partial pressure] in Venous blood
646
3548
1.94
48.54
5.0
3.7
kpa
5.8
5.9
0.27
625
3446
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1650
11785
1.59
48.40
3.2
3.0
ng/l
1781.4
1303.0
1.82
1443
10061
(3019060) Gas panel - Arterial blood
498
2501
2.10
48.07
6.0
4.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2099
15871
1.55
47.75
4.0
3.6
ng/l
67.2
54.6
0.17
1495
10565
(3002032) Base excess in Venous blood by calculation
640
3531
1.93
47.38
5.1
3.7
mmol/l
2.0
2.0
0.05
523
2893
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2278
17647
1.53
45.69
2.2
2.0
pmol/l
94.1
96.6
1.45
1241
8928
(3044889) 12 lead EKG panel
3496
29861
1.54
42.90
4.2
3.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
473
2433
2.04
42.62
4.3
3.4
kpa
5.2
5.2
1.26
437
2245
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1311
9124
1.59
41.74
1.8
1.7
mg/l
1.1
1.1
0.08
1013
6884
(3009343) pH of Capillary blood
465
2398
2.03
41.57
4.2
3.4
ph
7.4
7.4
0.19
54
288
(3023520) Reticulocytes [#/volume] in Blood
556
3056
1.92
41.35
3.1
2.2
e9/l
73.0
69.9
1.26
425
2315
(3017181) Myelocytes/100 leukocytes in Blood
569
3181
1.89
40.12
3.9
3.9
%
1.0
0.7
1.33
154
648
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
159
504
3.22
39.92
2.0
1.3
u/l
19.7
28.7
3.09
145
387
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
447
2315
2.02
39.43
4.1
3.4
mmol/l
2.1
1.8
1.05
341
1703
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1034
6888
1.63
39.13
3.1
2.1
mmol/l
2.5
2.4
6.02
910
5874
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
340
1592
2.22
39.04
6.7
4.7
%
1.8
1.7
0.82
321
1487
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
28
12
23.46
38.65
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
548
3067
1.88
38.43
4.0
3.9
%
0.1
0.1
0.32
147
603
(3002179) Metamyelocytes/100 leukocytes in Blood
531
2948
1.89
38.17
3.8
3.7
%
0.8
0.5
1.23
112
492
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
169
571
3.03
38.09
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1347
9601
1.55
38.00
1.6
1.5
nmol/l
20.5
20.7
0.13
1187
8155
(3008152) Bicarbonate [Moles/volume] in Arterial blood
455
2411
1.97
37.56
8.6
6.9
mmol/l
25.2
24.6
2.91
425
2228
(3002385) Erythrocyte distribution width [Ratio]
3939
34926
1.56
37.36
23.9
14.4
%
13.9
13.6
20.54
3900
34099
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
649
3868
1.78
37.00
3.3
3.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
332
1573
2.19
36.99
6.7
4.8
%
0.9
0.9
0.93
313
1473
(3005719) IgG [Mass/volume] in Serum or Plasma
508
2814
1.89
36.71
2.6
2.3
g/l
10.2
10.7
1.94
462
2560
(40768797) Stomach Pathology biopsy report
893
5823
1.65
36.54
1.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
302
1387
2.25
36.32
2.1
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
486
2667
1.91
36.12
2.4
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
701
4300
1.73
36.07
1.4
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4400
40158
1.70
36.07
7.2
5.9
mmol/mol
40.6
39.8
6.66
4166
37300
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
319
1515
2.18
35.32
2.3
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
46
57
8.13
34.57
1.2
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
2536
20780
1.44
34.54
3.9
3.6
estimate
0.0
0.0
0.43
569
3497
(3044290) Cell count panel - Cerebral spinal fluid
205
809
2.60
34.48
1.4
1.3
—
—
—
0
0
(3019225) pH of Specimen
645
3914
1.74
34.39
6.9
3.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
257
1138
2.33
33.67
3.2
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
4738
44347
1.96
33.62
19.2
11.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
2502
20565
1.43
32.83
5.3
4.7
estimate
0.0
0.0
0.80
592
3612
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
135
437
3.15
32.77
3.1
2.1
u/ml
1065.9
77.3
0.54
123
396
(3047181) Lactate [Moles/volume] in Blood
261
1182
2.27
32.43
8.2
5.8
mmol/l
1.3
1.3
0.14
234
1029
(3028626) Oxygen [Partial pressure] in Capillary blood
198
794
2.55
32.23
3.7
2.9
kpa
8.1
8.1
0.18
181
732
(3026493) Urate [Moles/volume] in Serum or Plasma
1482
11082
1.48
32.21
2.8
2.3
umol/l
5065.7
4662.9
0.13
1294
9538
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
215
898
2.46
32.11
1.4
1.3
e6/l
106.2
25.5
0.63
156
697
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
660
4105
1.70
32.04
1.8
1.7
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
215
899
2.45
32.03
1.4
1.4
e6/l
2065.0
1012.8
0.70
168
739
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
330
1657
2.06
31.55
1.6
1.6
g/l
1.7
1.5
1.16
285
1420
(3025159) Blasts/100 leukocytes in Blood
507
2941
1.80
31.43
4.0
4.0
%
0.1
0.2
0.16
120
528
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
312
1539
2.09
31.29
2.8
1.5
u/ml
125.5
27.4
0.51
300
1469
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
656
4119
1.68
30.65
1.9
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
393
2125
1.92
30.40
1.5
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2477
20498
1.41
30.30
3.9
3.5
estimate
0.0
0.0
0.80
578
3543
(3009508) Creatinine [Moles/volume] in Urine
1781
13923
1.43
30.09
3.5
3.2
mmol/l
7.4
7.5
0.37
1540
11718
(1617658) Protocol used for examination of sentinel lymph nodes
34
5
68.33
29.89
1.0
1.0
—
—
—
0
0
(3013512) EKG study
1571
12020
1.44
29.79
4.3
3.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
54
94
5.80
29.71
1.1
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
303
1508
2.07
29.66
2.4
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
217
944
2.36
29.61
4.2
3.0
mmol/l
25.5
24.8
1.38
181
828
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
303
1509
2.07
29.60
2.4
1.4
g/l
7.4
7.4
0.11
216
1115
(3003694) ABO and Rh group [Type] in Blood
1389
10401
1.46
29.46
1.4
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
302
1506
2.07
29.40
2.4
1.4
g/l
3.7
3.8
1.03
214
1069
(3007164) IgA [Mass/volume] in Serum or Plasma
1111
7964
1.51
29.31
1.4
1.3
g/l
2.4
2.4
0.24
679
4714
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
115
362
3.23
29.27
1.6
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
501
2962
1.77
29.04
3.6
3.1
kpa
4.7
4.6
0.58
483
2870
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
185
756
2.50
28.96
3.0
2.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
285
1402
2.09
28.77
2.3
1.4
g/l
9.8
10.4
1.16
235
1164
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4529
42128
1.67
28.70
5.3
4.6
mmol/l
6.0
5.9
4.34
4225
38567
(3037756) Immunofixation for Serum or Plasma
169
667
2.59
28.45
1.6
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
127
437
2.95
27.78
3.9
2.8
%
1.3
1.1
0.30
91
332
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4804
45518
1.95
27.68
13.1
8.9
u/l
27.6
26.1
2.71
4704
43736
(40760892) CBC W Ordered Manual Differential panel - Blood
1214
8950
1.47
27.60
4.2
4.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
163
643
2.59
27.48
1.4
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
792
5348
1.57
27.30
22.8
26.0
inr
1.3
1.3
0.09
152
776
(3023410) Appearance of Cerebral spinal fluid
115
378
3.09
27.25
1.6
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
632
4054
1.64
26.98
1.7
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
164
655
2.55
26.95
3.5
2.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
328
1747
1.94
26.49
4.3
3.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
280
1419
2.03
26.07
2.4
1.4
g/l
3.0
3.0
0.17
215
1093
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
222
1034
2.20
25.77
1.3
1.3
mg/l
522.7
489.6
0.54
209
974
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
330
1784
1.91
25.48
4.8
4.3
mmol/l
24.1
24.2
0.20
312
1585
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
375
2112
1.84
25.48
1.7
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
388
2209
1.82
25.45
1.6
1.5
g/l
1.2
1.2
0.16
349
2013
(3020682) Albumin/Creatinine [Ratio] in Urine
1745
13891
1.39
25.44
4.3
4.0
mg/mmol
12.1
8.1
1.87
1176
8684
(3041096) Erythrocytes [Presence] in Urine by Automated
1415
10882
1.42
25.20
3.8
3.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
264
1328
2.04
25.09
2.3
1.8
ug/l
2.5
1.5
0.98
232
1153
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
237
1145
2.12
25.08
2.3
3.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
688
4580
1.58
25.07
1.9
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
119
419
2.88
25.00
1.5
1.3
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
87
254
3.47
25.00
1.3
1.2
mmol/l
33.2
36.0
0.51
81
215
(3012516) Albumin [Mass/volume] in Urine
1666
13197
1.39
24.88
3.6
3.3
mg/l
539.8
327.2
0.89
1131
8239
(3039000) Anion gap in Blood
187
823
2.32
24.87
9.6
6.7
mmol/l
10.8
11.3
1.36
169
731
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
68
168
4.09
24.83
4.7
1.1
u/ml
299.8
147.9
0.41
22
44
(3018572) Chloride [Moles/volume] in Blood
187
824
2.32
24.80
9.6
6.7
mmol/l
105.2
104.8
0.39
169
732
(40768793) Breast Pathology biopsy report
96
300
3.24
24.78
1.4
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
38
56
6.83
24.59
1.4
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
224
1070
2.14
24.41
3.0
3.5
u/ml
0.4
0.3
0.91
139
614
(1616796) Gas panel - Central venous blood
181
798
2.31
23.98
3.8
3.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
4938
47470
2.27
23.95
30.2
17.7
e9/l
256.1
251.3
5.51
4870
46188
(3037522) Nuclear Ab [Titer] in Serum
848
5969
1.50
23.87
1.4
1.3
titre
567.8
535.4
0.16
170
1300
(3019309) Folate [Moles/volume] in Red Blood Cells
1057
7772
1.45
23.87
1.8
1.7
nmol/l
1087.7
1166.0
2.10
838
5870
(3034860) Kappa light chains.free [Mass/volume] in Serum
236
1160
2.08
23.87
3.1
1.5
mg/l
50.5
46.8
0.20
187
928
(3027273) Bicarbonate [Moles/volume] in Venous blood
339
1891
1.85
23.73
5.1
3.1
mmol/l
25.2
25.3
0.24
324
1821
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
235
1157
2.08
23.67
3.1
1.5
mg/l
41.8
39.0
0.13
186
920
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
105
356
2.99
23.62
1.2
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
54
116
4.69
23.55
1.4
1.5
ug/l
0.5
0.4
0.67
33
70
(3024731) MCV [Entitic volume]
4938
47496
2.25
23.47
30.0
17.6
fl
90.9
91.0
0.95
4913
46788
(3035941) MCH [Entitic mass]
4938
47497
2.25
23.45
30.0
17.6
pg
30.2
30.3
9.94
4913
46789
(3000963) Hemoglobin [Mass/volume] in Blood
4939
47514
2.25
23.39
30.4
17.8
g/l
134.3
136.7
24.34
4911
46801
(3026361) Erythrocytes [#/volume] in Blood
4938
47504
2.24
23.33
30.1
17.7
e12/l
4.5
4.5
5.74
4860
46064
(3010813) Leukocytes [#/volume] in Blood
4938
47512
2.24
23.18
30.2
17.7
e9/l
7.1
6.7
20.38
4860
46062
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
227
1122
2.07
22.63
3.1
1.5
ratio
1.6
2.4
0.48
11
109
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2977
26051
1.34
22.48
3.1
2.9
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
338
1916
1.82
22.45
3.4
2.5
e6/l
0.2
0.3
0.51
332
1859
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
544
3530
1.61
21.94
3.1
2.9
ng/l
204.0
184.5
0.49
505
3225
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
193
908
2.17
21.88
1.2
1.2
mmol/l
3.6
3.8
1.84
176
848
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
59
145
4.10
21.73
1.6
1.4
pmol/l
14.8
16.4
0.63
53
119
(46235355) HIV 1 and 2 tests - Meaningful Use set
868
6251
1.47
21.61
1.8
1.8
—
—
—
0
0
(3010421) pH of Blood
200
962
2.12
21.43
3.6
3.9
ph
7.4
7.4
0.19
171
784
(3012501) Base excess in Blood by calculation
175
799
2.23
21.37
3.6
4.0
mmol/l
2.5
2.4
0.24
121
533
(3052851) Hemolysis interference index of Serum or Plasma
221
1105
2.05
21.36
3.3
3.2
—
—
—
0
0
(3015736) pH of Urine
1929
15947
1.34
20.94
3.5
3.3
—
5.4
—
0
5
(40760888) Immunoglobulin light chains.free panel - Serum
183
858
2.18
20.94
2.9
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
239
1238
1.98
20.93
2.6
2.6
g/l
0.3
0.3
0.03
112
423
(3004119) Hemoglobin [Mass/volume] in Venous blood
400
2437
1.70
20.64
3.7
3.1
g/l
127.6
131.2
2.30
380
2367
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
241
1262
1.95
20.46
2.4
1.5
g/l
0.4
0.5
0.12
203
1077
(3000570) Elastase.pancreatic [Mass/mass] in Stool
227
1166
1.99
20.37
1.5
1.4
ug/g
239.9
294.0
3.98
129
677
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
27
34
7.98
20.01
1.3
1.1
nmol/l
3.8
5.1
0.83
27
34
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
204
1016
2.05
19.95
1.5
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
228
1189
1.96
19.59
2.2
1.4
g/l
37.4
37.8
0.52
187
1005
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
203
1020
2.03
19.38
2.3
1.4
g/l
0.0
0.0
0.00
181
942
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
217
1119
1.98
19.26
2.3
1.4
g/l
0.0
0.0
1.32
195
1023
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1210
9411
1.37
19.23
1.3
1.3
u/ml
1.0
1.9
4.69
303
2543
(40761536) Microorganisms panel - Urine sediment
506
3328
1.58
19.18
4.5
3.8
—
—
—
0
0
(3012565) Volume of 24 hour Urine
66
193
3.45
19.00
1.8
2.1
ml
2086.6
1965.3
0.42
61
170
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
66
194
3.43
18.85
1.8
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
113
450
2.55
18.78
1.7
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
723
5165
1.47
18.53
1.6
1.6
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
203
1039
1.99
18.42
2.3
1.4
g/l
0.0
0.0
0.00
181
945
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
305
1785
1.75
18.17
1.9
1.9
u/l
38.8
39.0
0.04
270
1556
(3023183) Ammonium ion [Moles/volume] in Plasma
159
766
2.11
17.03
2.3
2.7
umol/l
32.1
35.0
0.75
138
660
(3017354) Segmented neutrophils/100 leukocytes in Blood
83
300
2.80
16.74
4.0
2.7
%
61.4
58.6
0.36
42
198
(3045142) Bone marrow Pathology biopsy report
75
258
2.94
16.56
1.3
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
241
1362
1.81
16.18
2.4
2.4
ug/l
488.0
699.9
0.52
228
1275
(3042631) Mycobacterium sp identified in Specimen
106
451
2.38
15.36
2.5
3.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
129
597
2.19
15.34
1.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
390
2543
1.58
15.28
1.4
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
84
322
2.64
15.16
4.7
3.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
128
594
2.18
15.12
5.3
5.6
iu/ml
221.2
615.6
—
10
79
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
262
1549
1.73
15.08
4.5
3.6
mmol/l
25.0
24.9
0.39
246
1431
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
187
998
1.91
15.07
1.4
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
167
859
1.98
15.00
1.6
1.9
nmol/l
1.0
0.8
1.45
146
717
(3024928) Oxygen saturation in Venous blood
163
835
1.98
14.81
3.8
3.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1550
12885
1.29
14.80
5.4
3.7
ug/l
2.0
2.2
0.24
1411
11624
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
185
991
1.90
14.74
2.3
2.5
g/l
3.9
3.5
2.27
176
928
(3048689) Calprotectin [Mass/mass] in Stool
689
5088
1.41
14.53
2.1
2.3
ug/g
129.8
132.9
0.09
529
3994
(3009445) Proteinase 3 Ab [Units/volume] in Serum
297
1836
1.66
14.48
1.4
1.6
u/ml
5.7
17.1
—
6
48
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
36
84
4.31
14.27
1.6
1.7
ng/l
167.1
124.6
0.51
36
84
(40768441) Liver Pathology biopsy report
60
200
3.02
14.05
1.2
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
222
1278
1.77
14.04
1.5
1.6
g/l
0.2
0.2
1.51
202
1204
(40767503) Oxygen content in Capillary blood by calculation
152
777
1.99
13.92
2.7
2.4
%
16.8
16.5
0.45
85
407
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
146
738
2.01
13.80
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
146
738
2.01
13.80
1.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1859
15924
1.26
13.64
4.2
3.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4589
43951
1.44
13.39
5.5
5.1
mmol/l
2.7
2.8
7.36
4270
40707
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
293
1847
1.62
13.23
3.2
2.7
%
1.4
1.3
1.70
288
1831
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
98
431
2.30
13.22
6.9
6.6
mg/l
11.8
11.7
0.12
88
394
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
223
1309
1.74
13.19
1.5
1.6
g/l
1.2
1.2
1.17
205
1229
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
143
730
1.99
13.17
1.3
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
145
749
1.96
12.92
1.5
1.4
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
14
13
10.80
12.85
1.0
1.0
pmol/l
85.2
88.2
—
6
5
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
89
381
2.36
12.79
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
656
4919
1.38
12.54
1.7
1.7
%
1.5
1.5
0.48
570
4327
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
466
3297
1.45
12.36
3.2
2.3
ml/min/173m2
68.4
66.3
0.28
206
1226
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
171
948
1.83
12.30
3.1
3.1
mg/l
1.6
1.6
0.00
158
856
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
280
1779
1.61
12.25
4.6
3.7
%
48.9
48.8
0.03
273
1753
(3020891) Body temperature
252
1560
1.65
12.25
4.9
4.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
283
1808
1.60
12.11
3.2
2.7
%
0.6
0.7
0.80
278
1721
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
178
1009
1.79
11.91
2.4
2.4
%
174.9
184.4
0.77
167
957
(3025941) Bacteria identified in Stool by Culture
336
2244
1.53
11.84
1.3
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
60
221
2.74
11.79
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
918
7306
1.31
11.76
3.2
2.7
ug/l
0.8
0.7
0.83
657
4788
(40768806) Pleura Pathology biopsy report
62
233
2.68
11.72
1.8
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
30
71
4.24
11.71
3.1
2.7
—
—
—
0
0
(3000492) Spirometry study
544
4000
1.40
11.65
1.5
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4505
43171
1.37
11.60
4.9
4.5
mmol/l
4.6
4.7
12.40
4219
40189
(3008037) Lactate [Moles/volume] in Venous blood
155
851
1.85
11.52
3.5
2.9
mmol/l
1.5
1.7
1.85
147
827
(3000494) Fungus identified in Specimen by Culture
644
4886
1.36
11.39
1.6
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
191
1120
1.73
11.39
2.0
2.0
mg/l
10.9
10.8
0.05
173
1030
(4281824)
61
231
2.66
11.38
1.2
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
475
3426
1.43
11.35
1.2
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4346
41450
1.33
11.32
4.4
4.0
mmol/l
1.4
1.3
23.44
4024
38080
(3025549) Creatine [Moles/time] in 24 hour Urine
19
31
6.15
11.19
1.5
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
332
2244
1.51
11.07
2.5
2.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4475
42898
1.35
10.99
4.9
4.5
mmol/l
1.4
1.5
36.90
4167
39717
(3029937) Albumin [Presence] in Urine by Test strip
1324
11131
1.26
10.85
4.3
4.0
estimate
0.0
0.0
0.22
576
3555
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
186
1103
1.71
10.67
2.1
2.2
%
92.8
92.2
0.13
175
1024
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
60
233
2.59
10.67
1.3
1.3
u/l
248.2
319.2
1.01
54
220
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
174
1017
1.74
10.52
1.9
1.9
iu/l
3.4
4.5
0.98
56
363
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
134
724
1.87
10.51
1.5
1.4
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
26
60
4.35
10.50
1.2
1.2
ug/l
320.4
53.2
0.41
13
28
(3003434) Protein [Mass/volume] in Pleural fluid
78
346
2.27
10.40
1.6
1.5
g/l
33.0
29.6
1.34
69
303
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
93
445
2.11
10.29
1.1
1.1
—
2.7
—
0
6
(3007566) Smooth muscle Ab [Titer] in Serum
186
1115
1.69
10.27
1.2
1.2
titre
84.0
155.4
0.66
15
95
(3006184) Hemoglobin [Mass/volume] in Capillary blood
155
884
1.78
10.21
2.3
2.1
g/l
131.6
131.3
0.05
103
638
(3024980) IgG subclass 4 [Mass/volume] in Serum
128
689
1.88
10.17
1.5
1.6
g/l
0.6
0.8
1.48
96
522
(3003327) Ova and parasites identified in Stool by Light microscopy
215
1344
1.63
10.10
1.7
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1234
10363
1.25
10.10
4.5
3.6
%
21.3
24.0
8.20
618
4784
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1394
11873
1.24
10.03
1.7
1.6
mmol/l
1.5
1.4
6.98
1194
9923
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
89
424
2.12
9.98
1.0
1.1
—
43.2
—
0
8
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
230
1470
1.59
9.87
1.5
1.7
titre
226.7
306.0
—
6
70
(3036489) Thrombin time
221
1400
1.60
9.84
1.9
2.0
s
20.8
21.2
0.74
184
1199
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
125
676
1.87
9.80
1.5
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
191
1173
1.65
9.64
4.4
4.4
mmol/l
3.8
3.9
2.48
178
1110
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
84
398
2.13
9.57
1.3
1.1
u/l
49.6
57.9
1.34
67
260
(4010399)
433
3168
1.40
9.53
1.5
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
181
1101
1.67
9.49
2.2
2.0
u/l
10814.5
3932.6
1.05
44
448
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
57
231
2.48
9.33
1.4
1.1
u/l
79.0
81.5
0.09
50
199
(3035880) pH of Pleural fluid
41
140
2.94
9.32
1.3
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
22
49
4.50
9.29
1.1
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
61
256
2.40
9.27
1.2
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
70
315
2.24
9.08
1.2
1.2
mmol/l
2.1
2.1
0.10
64
296
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
66
290
2.29
9.05
1.2
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
69
309
2.25
9.05
1.6
1.5
e6/l
1271.3
3167.4
1.41
53
225
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
51
200
2.57
8.95
1.3
1.2
%
48.0
57.7
—
6
21
(3034770) Mitochondria Ab [Titer] in Serum
182
1135
1.63
8.68
1.2
1.2
titre
1561.4
995.1
—
7
39
(3001556) Androgen free Index in Serum or Plasma
17
32
5.33
8.67
1.6
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1097
9228
1.24
8.66
1.7
1.7
pmol/l
5844609.3
35408129.2
3.26
924
7665
(3045716) Anion gap in Serum or Plasma
51
204
2.52
8.61
2.0
2.0
mmol/l
8.4
9.5
1.60
42
158
(3017569) Oxygen content in Arterial blood
51
205
2.50
8.53
2.1
1.9
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
138
804
1.74
8.51
3.7
3.0
mmol/l
7.6
7.6
0.05
131
781
(3044242) Glucose [Moles/volume] in Arterial blood
49
194
2.54
8.46
1.9
1.8
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
115
638
1.82
8.38
1.2
1.2
u/l
26.6
27.8
0.06
104
552
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
87
440
1.99
8.37
1.4
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
124
705
1.78
8.33
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
4046
38584
1.24
8.30
21.3
13.1
%
39.5
40.0
2.83
2868
27484
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
98
520
1.90
8.21
1.5
1.5
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
10
11
9.11
8.08
1.2
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
53
223
2.39
8.06
1.3
1.1
u/l
21.8
19.2
0.18
44
190
(3016650) Hepatitis A virus Ab [Presence] in Serum
110
612
1.81
7.96
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
62
281
2.22
7.95
1.0
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
13
21
6.20
7.71
2.1
1.0
ug/l
3.5
1.5
—
8
10
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
39
145
2.70
7.65
2.5
2.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
382
2841
1.37
7.63
1.2
1.2
iu/ml
135.8
145.1
0.16
122
1108
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
59
268
2.22
7.55
1.7
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
59
268
2.22
7.55
1.7
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
59
268
2.22
7.55
1.7
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
56
250
2.25
7.47
3.3
2.2
e9/l
1.0
1.1
0.41
33
141
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
107
604
1.79
7.41
1.3
1.5
u/ml
114.2
108.7
0.22
19
116
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
109
2.95
7.37
1.0
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
39
148
2.65
7.37
1.8
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
39
148
2.65
7.37
1.8
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
39
148
2.65
7.37
1.8
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
39
148
2.65
7.37
1.8
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
59
271
2.19
7.36
1.7
1.5
e6/l
37299.4
58740.4
0.32
38
161
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
48
203
2.38
7.25
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
114
661
1.74
7.22
1.2
1.2
u/ml
242.7
274.8
0.56
72
423
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
44
180
2.46
7.15
2.7
2.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
109
628
1.75
7.06
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
93
512
1.83
7.01
1.4
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
122
728
1.69
6.98
2.0
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
15
31
4.85
6.92
1.0
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
45
189
2.39
6.92
2.7
2.0
%
10.6
14.2
1.15
17
92
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
63
305
2.08
6.90
1.1
1.2
mg/l
39.3
37.2
0.22
53
251
(3004451) EKG impression Narrative
46
196
2.36
6.86
1.2
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
65
321
2.04
6.76
3.5
2.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
80
425
1.90
6.75
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
86
468
1.85
6.74
1.6
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
56
262
2.15
6.70
1.6
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
28
94
2.99
6.64
3.2
2.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
919
7784
1.22
6.62
1.3
1.3
iu/ml
32.2
33.5
0.12
279
2419
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
52
238
2.20
6.58
1.7
1.5
u/l
4.2
5.6
0.37
30
103
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
16
37
4.33
6.48
1.9
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
102
592
1.74
6.48
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
83
455
1.84
6.38
1.6
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
175
1168
1.52
6.32
1.4
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
393
3023
1.33
6.32
2.5
2.4
au/ml
17.3
25.5
—
6
161
(3045788) Cell count panel - Pleural fluid
51
236
2.17
6.30
1.6
1.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
64
323
1.99
6.30
1.3
1.2
ug/l
2.2
3.0
1.67
54
282
(3023511) Choriogonadotropin [Units/volume] in Urine
101
592
1.72
6.21
1.4
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
171
1142
1.51
6.17
1.1
1.1
u/ml
13.6
5.7
0.51
19
125
(3014271) Vancomycin [Susceptibility]
44
194
2.28
6.11
2.8
3.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
27
94
2.88
6.03
3.2
2.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
361
2764
1.33
6.00
1.3
1.3
au/ml
28.4
53.8
—
5
123
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
26
89
2.93
5.99
1.5
1.3
%
64.0
58.8
0.28
21
72
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
44
196
2.26
5.97
1.1
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
27
4.82
5.97
1.1
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
470
3735
1.28
5.94
2.5
2.4
ug/l
6.1
7.9
1.15
415
3268
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
47
216
2.19
5.92
1.1
1.1
u/l
1.2
1.1
0.35
21
102
(3024522) Salmonella sp identified in Specimen by Organism specific culture
82
460
1.80
5.88
1.6
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
81
454
1.80
5.83
1.6
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
88
506
1.75
5.81
2.6
2.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
371
2866
1.32
5.80
3.0
2.7
e9/l
4.3
4.1
0.95
285
2192
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
58
292
2.00
5.78
1.1
1.1
mg/l
258.0
254.7
0.05
51
254
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
37
155
2.40
5.78
1.0
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
50
239
2.10
5.72
1.4
1.4
nmol/l
1.4
1.3
0.29
44
182
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
60
307
1.97
5.72
1.8
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
80
450
1.79
5.70
1.6
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
41
181
2.28
5.70
4.0
4.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
248
1806
1.39
5.70
1.3
1.3
u/ml
0.2
0.8
2.09
19
171
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
80
451
1.79
5.66
1.6
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
63
329
1.93
5.66
2.4
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1134
9925
1.18
5.65
3.5
3.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
158
1059
1.51
5.64
1.2
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
43
195
2.22
5.62
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
43
195
2.22
5.62
4.1
3.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
867
7414
1.20
5.60
1.3
1.3
u/ml
8.0
13.1
1.53
315
2898
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
77
432
1.79
5.55
1.3
1.4
—
—
—
0
0
(4027681)
48
229
2.11
5.53
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
124
796
1.57
5.39
1.3
1.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
30
118
2.55
5.36
1.1
1.1
%
86.7
92.6
0.29
15
54
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
47
226
2.09
5.32
1.4
1.7
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
10
18
5.56
5.32
2.8
2.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
18
53
3.40
5.30
2.2
1.3
ng/l
119.9
109.6
0.12
11
21
(3033705) Calcium.ionized [Moles/volume] in Venous blood
77
439
1.77
5.28
2.4
2.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
62
331
1.88
5.25
1.2
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
129
842
1.55
5.23
1.4
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
63
339
1.87
5.21
1.7
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
220
1600
1.39
5.13
1.6
1.6
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
30
121
2.49
5.11
1.1
1.1
%
85.6
91.3
0.44
15
54
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
105
658
1.61
5.08
1.1
1.1
iu/ml
1358.2
15933.6
0.47
24
147
(3051611) Lipemic interference index of Serum or Plasma
66
364
1.82
5.06
3.8
3.4
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
19
60
3.17
5.03
1.6
1.4
%
22.6
31.8
0.50
14
46
(44790047)
66
365
1.82
5.02
1.4
1.4
—
—
—
0
0
(44790049)
66
365
1.82
5.02
1.4
1.4
—
—
—
0
0
(44790048)
66
365
1.82
5.02
1.4
1.4
—
—
—
0
0
(44806118)
66
365
1.82
5.02
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
145
980
1.49
5.01
4.4
3.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
37
166
2.24
4.99
1.3
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
34
148
2.31
4.92
1.1
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
37
169
2.20
4.80
1.3
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
21
73
2.88
4.75
1.9
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
110
709
1.56
4.75
1.5
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
343
2697
1.29
4.75
1.3
1.3
u/ml
156.9
236.2
1.70
323
2501
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
45
223
2.03
4.75
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
230
1710
1.36
4.71
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
84
509
1.66
4.67
1.2
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
61
338
1.81
4.64
1.3
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
51
267
1.92
4.62
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
92
574
1.61
4.57
1.5
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
110
716
1.55
4.57
3.3
3.7
%
58.6
57.5
0.39
110
716
(3013139) Helicobacter pylori Ag [Presence] in Stool
373
2980
1.27
4.56
1.2
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
24
92
2.62
4.55
1.3
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
43
214
2.02
4.50
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
165
1175
1.42
4.39
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
234
1766
1.34
4.37
1.0
1.1
—
—
—
0
0
(4306422)
98
630
1.57
4.32
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
304
3841
0.78
4.31
1.3
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
43
218
1.98
4.29
3.0
2.2
%
36.1
45.9
—
7
30
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
191
2.05
4.28
1.3
1.4
—
—
—
0
0
(3019977) pH of Arterial blood
41
206
2.00
4.20
2.9
2.4
ph
7.4
7.4
0.80
18
73
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
16
51
3.14
4.20
1.2
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
16
51
3.14
4.20
1.2
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
83
517
1.62
4.18
1.1
1.1
g/l
1.5
1.5
0.07
77
454
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
46
3.27
4.18
1.1
1.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
20
73
2.75
4.18
1.7
1.3
%
2.5
3.0
0.09
20
62
(4062490)
75
456
1.65
4.16
1.4
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
21
79
2.67
4.15
1.2
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
47
249
1.90
4.15
1.1
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
134
929
1.45
4.14
1.2
1.2
u/ml
15.9
43.9
4.62
13
103
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
41
208
1.98
4.10
1.5
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
36
174
2.08
4.10
2.1
2.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
162
1166
1.40
4.09
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
164
1184
1.40
4.07
1.1
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
26
110
2.37
4.06
2.0
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
22
86
2.56
4.04
2.4
1.2
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
19
69
2.76
4.01
1.7
1.3
%
21.9
30.0
0.59
19
63
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
30
136
2.21
4.01
1.2
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
30
136
2.21
4.01
1.2
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
182
1341
1.37
4.00
1.5
1.6
iu/ml
0.1
2.5
0.52
46
271
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
26
111
2.35
3.98
2.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
26
111
2.35
3.98
2.0
1.4
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
9
14
6.44
3.98
7.3
4.9
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
49
268
1.84
3.94
1.1
1.1
nmol/l
7.1
8.0
0.05
14
59
(3028192) IgG subclass 2 [Mass/volume] in Serum
74
456
1.63
3.92
1.4
1.3
g/l
2.9
2.9
0.04
46
322
(3027135) IgG subclass 1 [Mass/volume] in Serum
74
456
1.63
3.92
1.4
1.3
g/l
6.5
6.6
0.11
46
323
(3024139) IgG subclass 3 [Mass/volume] in Serum
74
456
1.63
3.92
1.4
1.3
g/l
0.3
0.4
1.14
47
323
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
26
112
2.33
3.91
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
46
248
1.86
3.87
1.1
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
41
213
1.93
3.85
1.3
1.3
nmol/l
133.5
136.7
0.17
41
213
(3011288) Drugs identified in Urine by Screen method
120
828
1.46
3.83
2.3
3.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
58
337
1.73
3.83
1.2
1.2
titre
80.0
201.8
—
7
67
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
25
107
2.34
3.82
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
80
507
1.59
3.79
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
61
362
1.69
3.74
3.3
4.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
187
2471
0.75
3.74
1.5
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
57
332
1.72
3.74
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
57
332
1.72
3.74
1.2
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
24
102
2.36
3.73
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
16
55
2.92
3.73
1.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
19
72
2.65
3.72
3.7
2.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
37
188
1.98
3.72
3.1
2.1
e6/l
656.1
470.7
0.73
29
162
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
57
333
1.72
3.70
1.2
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
10
25
4.01
3.69
1.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
10
25
4.01
3.69
1.1
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
15
50
3.01
3.68
2.5
2.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
19
73
2.61
3.63
1.1
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
35
176
2.00
3.62
1.9
2.4
umol/l
83.6
150.9
1.40
18
95
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
25
110
2.28
3.61
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
57
336
1.70
3.59
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
57
336
1.70
3.59
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
57
336
1.70
3.59
1.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
74
467
1.59
3.59
1.4
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
25
111
2.26
3.54
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
91
605
1.51
3.52
1.1
1.1
%
122.8
116.6
1.07
77
545
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
9
17
5.30
3.50
1.7
1.3
nmol/l
1.4
1.6
—
9
17
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
6
10.01
3.49
1.0
1.0
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
17
63
2.70
3.48
1.4
1.4
nmol/l
7.2
483642.3
—
9
55
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
21
87
2.42
3.46
1.2
1.2
%
59.2
77.9
—
5
25
(3024891) Influenza virus A+B Ag [Presence] in Specimen
133
956
1.40
3.44
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
301
3703
0.80
3.44
1.8
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
158
1171
1.36
3.40
1.3
1.3
u/ml
10.7
4.9
0.50
24
187
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
66
411
1.61
3.40
1.5
1.5
%
39.4
31.6
0.85
45
253
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
55
327
1.69
3.38
1.1
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
84
555
1.52
3.36
1.6
1.5
%
58.0
59.0
0.08
57
343
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
37
196
1.89
3.33
1.2
1.1
u/l
31.7
21.0
0.32
27
143
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
35
182
1.93
3.32
3.3
2.1
e9/l
0.3
0.2
0.27
28
161
(3014148) Varicella zoster virus Ab [Titer] in Serum
73
469
1.56
3.31
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
44
247
1.79
3.31
1.3
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
77
501
1.55
3.31
2.6
2.2
mg/l
25.2
23.2
0.12
23
126
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
37
197
1.88
3.28
1.2
1.1
u/l
99.6
81.2
0.39
28
149
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
105
731
1.45
3.26
1.8
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
163
1226
1.34
3.21
1.5
2.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
155
1157
1.35
3.21
1.3
1.3
u/ml
2.3
5.3
0.57
19
116
(3011648) Oxygen content in Venous blood
53
317
1.68
3.21
1.9
2.4
%
11.2
11.2
0.05
53
317
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
56
340
1.65
3.20
1.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
10
28
3.58
3.19
1.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
36
192
1.88
3.19
2.1
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
84
562
1.50
3.19
1.4
2.9
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
14
49
2.86
3.18
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
95
652
1.47
3.18
1.1
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
27
130
2.08
3.17
1.9
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
40
222
1.81
3.14
1.2
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
163
1231
1.33
3.13
1.5
2.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
13
44
2.96
3.13
1.0
1.5
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
20
86
2.33
3.07
1.2
1.2
%
92.3
81.2
—
6
26
(3016879) Cocaine [Presence] in Urine
152
1140
1.34
3.07
1.5
2.3
—
—
—
0
0
(3000012) Reticulocyte production index
36
195
1.85
3.05
1.4
1.4
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
6
8
7.51
3.05
3.2
11.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
163
1237
1.33
3.04
1.5
2.2
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
5
10.01
2.98
7.2
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
12
40
3.00
2.97
1.4
1.1
—
—
—
0
0
(4268621)
67
436
1.54
2.92
2.8
2.3
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
8
17
4.71
2.91
5.9
4.9
umol/l
590.8
386.9
—
8
17
(3025886) Oxalate [Mass/time] in 24 hour Urine
6
9
6.67
2.86
1.3
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
26
129
2.02
2.85
1.3
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
29
150
1.94
2.84
1.5
1.4
—
1475413.6
—
0
11
(40761539) Cells [Type] in Urine sediment by Light microscopy
18
77
2.34
2.81
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3743
36358
1.11
2.79
26.0
15.5
g/l
331.3
332.5
14.42
3728
36112
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
27
137
1.98
2.79
2.4
2.6
%
45.8
43.8
0.19
14
49
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
53
2.65
2.79
12.1
11.5
mmol/l
5.5
5.9
0.21
14
53
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
91
639
1.43
2.75
1.1
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
31
166
1.87
2.75
1.1
1.1
ng/l
161.9
194.2
—
7
40
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
42
2.86
2.74
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
55
348
1.59
2.72
2.3
2.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
25
125
2.00
2.70
2.4
2.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
185
1455
1.28
2.69
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
58
374
1.56
2.66
1.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
29
154
1.89
2.65
1.6
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
29
154
1.89
2.65
1.6
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
76
521
1.47
2.62
1.8
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
128
961
1.34
2.62
1.5
2.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
126
944
1.34
2.61
1.2
1.2
u/ml
2.4
5.1
—
8
68
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
256
2101
1.23
2.59
1.7
1.9
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
55
354
1.56
2.55
1.3
1.3
mmol/l
11.4
11.6
0.05
18
82
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
16
68
2.36
2.55
1.1
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
15
62
2.42
2.53
1.2
1.4
%
39.3
49.4
—
9
26
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
142
1090
1.31
2.51
2.2
2.4
ug/min
208.9
110.2
0.65
74
649
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
27
143
1.89
2.50
2.0
2.5
umol/l
29.9
29.5
0.08
21
103
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
158
1232
1.29
2.49
1.4
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
18
82
2.20
2.47
2.2
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
393
3377
1.18
2.46
1.9
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
146
1129
1.30
2.45
1.3
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
155
1209
1.29
2.44
1.5
2.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
109
809
1.35
2.43
1.7
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
140
1082
1.30
2.37
1.1
1.2
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
12
46
2.61
2.35
1.4
2.7
ml/dl
17.0
15.9
0.74
12
41
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
27
147
1.84
2.32
1.2
1.3
g/l
0.3
0.3
1.03
20
117
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
89
645
1.39
2.31
1.4
1.2
u/ml
1.9
3.6
1.73
27
212
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
17
78
2.18
2.30
1.4
1.9
umol/l
18.7
17.8
0.10
17
78
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
33
192
1.72
2.29
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
251
2086
1.21
2.29
3.9
3.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
11
41
2.69
2.27
2.1
1.6
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
8
23
3.48
2.27
1.6
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
41
255
1.61
2.23
1.1
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
13
54
2.41
2.19
1.1
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
9
30
3.00
2.14
1.2
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
25
137
1.83
2.13
1.8
1.5
ug/l
10.0
8.7
0.61
25
137
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
142
1118
1.28
2.12
1.2
1.3
miu/ml
212.2
219.1
0.08
48
531
(3045414) Leukocytes [Presence] in Urine
233
1942
1.21
2.09
2.0
1.8
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
57
389
1.47
2.08
1.4
1.3
nmol/l
1.4
1.5
0.19
50
349
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
5
10
5.00
2.07
1.0
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
5
10
5.00
2.07
1.2
1.4
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
20
3.50
2.05
1.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
13
56
2.32
2.04
3.1
1.7
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
61
424
1.44
2.03
13.5
22.9
mmol/l
7.7
7.2
0.28
52
347
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
432
3800
1.15
2.03
2.0
2.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
76
550
1.39
2.03
1.1
1.1
u/ml
6.6
2.9
0.67
38
248
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
36
224
1.61
1.99
1.6
1.5
—
—
—
0
0
(4198724)
26
148
1.76
1.98
1.2
3.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
237
1991
1.20
1.97
1.2
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
102
779
1.32
1.94
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
771
7050
1.11
1.93
1.6
1.5
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
31
187
1.66
1.93
1.1
1.1
%
102.8
94.5
0.51
20
148
(3026480) Teichoate Ab [Titer] in Serum
9
33
2.73
1.93
1.2
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
25
142
1.76
1.92
1.1
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
598
5397
1.12
1.90
4.8
4.7
%
31.5
32.5
1.29
442
3671
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
19
99
1.92
1.90
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
51
348
1.47
1.89
1.1
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
55
381
1.45
1.89
1.2
1.2
nmol/l
334.9
358.7
0.35
45
333
(3022689) Creatine [Moles/volume] in Urine
25
143
1.75
1.88
1.8
1.4
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
5
12
4.17
1.82
1.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
12
4.17
1.82
6.4
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
27
160
1.69
1.81
1.8
1.6
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
9
35
2.57
1.80
1.2
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
13
60
2.17
1.77
1.3
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
59
420
1.41
1.77
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
232
0.47
1.75
1.3
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
17
88
1.93
1.74
4.5
2.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
36
2.50
1.74
1.1
1.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
47
0.00
1.70
0.0
1.2
—
7.3
—
0
18
(3027456) Digoxin [Moles/volume] in Serum or Plasma
97
753
1.29
1.68
3.4
3.1
nmol/l
0.8
0.8
0.10
76
588
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
20
111
1.80
1.68
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
32
203
1.58
1.67
1.1
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
21
119
1.77
1.65
1.0
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
7
25
2.80
1.65
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
82
625
1.32
1.63
1.4
1.2
u/ml
8.3
4.5
0.62
40
270
(3019832) Treponema pallidum Ab [Presence] in Serum
347
3059
1.14
1.63
1.6
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
29
181
1.61
1.63
1.1
1.1
miu/ml
1083.0
1555.6
1.50
29
181
(3001964) Herpes simplex virus Ag [Presence] in Specimen
19
105
1.81
1.62
1.1
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
38
253
1.51
1.62
1.1
1.2
ratio
1.1
1.1
—
7
89
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
20
113
1.77
1.60
3.3
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
20
113
1.77
1.60
3.3
2.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
135
1100
1.23
1.58
2.0
1.5
e6/l
13319.4
10652.0
0.42
96
783
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
7
26
2.69
1.58
1.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
250
2158
1.17
1.57
1.0
1.1
—
—
—
0
0
(4024509)
56
405
1.39
1.57
1.5
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
42
289
1.46
1.54
3.4
2.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
80
615
1.31
1.52
5.3
5.1
umol/l
366.6
366.4
0.00
74
531
(3036071) Salmonella sp Ab [Titer] in Serum
23
138
1.67
1.51
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
20
116
1.73
1.48
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
197
1678
1.18
1.48
1.6
1.8
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
22
132
1.67
1.45
1.3
1.2
g/l
36.6
37.7
0.12
16
65
(3028717) Thiamine [Mass/volume] in Blood
9
38
2.37
1.45
1.4
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
18
102
1.77
1.44
2.1
1.5
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
16
3.13
1.44
1.0
1.7
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
5
16
3.13
1.44
1.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
12
59
2.04
1.43
1.1
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
111
898
1.24
1.42
3.7
3.3
mg/l
28.5
27.3
0.13
68
560
(3032868) Hemoglobin electrophoresis panel in Blood
9
40
2.25
1.40
1.3
1.6
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
96
1.77
1.38
1.2
1.1
—
—
—
0
0
(44806420)
20
119
1.68
1.37
2.5
2.3
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
6
23
2.61
1.36
1.7
2.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
39
273
1.43
1.34
1.3
1.2
—
—
—
0
0
(4146454)
63
479
1.32
1.33
2.7
2.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
167
1419
1.18
1.32
1.6
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
89
710
1.26
1.31
1.2
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
39
275
1.42
1.30
1.3
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
43
2.09
1.30
1.2
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
44
318
1.39
1.28
1.7
2.2
mmol/l
6.4
6.6
0.26
29
217
(3010937) Rubella virus Ab [Presence] in Serum
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
90
722
1.25
1.27
1.8
1.3
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
13
70
1.86
1.23
1.2
1.2
—
57.2
—
0
10
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
19
2.63
1.21
2.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
23
148
1.56
1.19
1.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
13
71
1.83
1.19
1.3
1.6
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
23
149
1.55
1.17
2.0
1.6
umol/l
31.4
28.7
0.51
23
144
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
14
79
1.77
1.16
1.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
59
759
0.77
1.16
1.6
1.6
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
20
2.50
1.15
1.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
20
2.50
1.15
3.2
3.4
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
8
40
2.00
1.12
1.0
1.1
—
3.8
—
0
7
(4015189)
20
127
1.58
1.11
2.4
2.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
31
2.26
1.10
1.3
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
23
152
1.52
1.08
1.4
1.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
7
32
2.19
1.08
2.7
1.9
—
—
—
0
0
(3025315) Body weight
7
32
2.19
1.08
6.0
3.9
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
32
2.19
1.08
1.0
1.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
46
347
1.33
1.07
1.0
1.5
promille
1.2
1.3
0.24
35
267
(3045683) HLA typing for celiac disease panel - Blood or Tissue
33
236
1.40
1.06
1.1
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
32
228
1.41
1.05
2.3
2.1
ug/min
24.7
225.1
—
9
57
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
12
67
1.79
1.04
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
112
1325
0.84
1.04
1.6
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
46
1.96
1.03
1.0
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
523
4860
1.08
1.01
1.7
1.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
35
2.00
1.00
2.1
2.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
51
651
0.78
0.98
1.4
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
23
156
1.48
0.98
1.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
36
1.95
0.97
1.1
2.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
116
1358
0.85
0.97
1.5
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
174
0.57
0.96
1.2
1.5
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
27
2.22
0.93
1.0
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
30
217
1.38
0.93
1.6
1.6
%
1.2
4.4
—
5
47
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
19
126
1.51
0.91
1.4
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
33
244
1.35
0.90
2.0
2.2
min
525.4
497.8
0.74
23
185
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
15
94
1.60
0.90
1.2
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
29
2.07
0.89
2.7
3.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
18
119
1.51
0.88
1.1
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
43
1.86
0.87
1.1
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
30
2.00
0.87
1.2
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
35
264
1.33
0.85
1.3
1.4
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
44
343
1.29
0.85
1.0
1.0
ng/l
818.8
720.8
0.63
33
224
(3052592) Norovirus Ag [Presence] in Stool
12
72
1.67
0.85
1.1
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
57
1.76
0.83
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
45
354
1.27
0.82
2.1
2.4
ml
731.8
638.0
0.72
30
242
(3024932) HLA-DR beta [Type]
17
113
1.51
0.82
1.2
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
52
417
1.25
0.82
1.5
1.3
e6/l
112969.0
108183.1
0.02
35
278
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
44
346
1.27
0.81
1.0
1.0
ng/l
33.0
46.3
2.01
32
227
(3033799) Differential panel - Peritoneal fluid
13
81
1.61
0.81
2.7
2.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
45
356
1.27
0.79
1.2
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
17
114
1.49
0.79
1.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
150
0.60
0.78
3.4
1.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
12
74
1.62
0.78
1.2
2.0
mmol/l
1.2
1.2
0.80
12
74
(3024869) Neuronal Ab [Presence] in Serum
12
74
1.62
0.78
1.0
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
34
1.77
0.76
1.2
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
19
132
1.44
0.75
1.6
1.7
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
24
2.08
0.74
1.2
1.7
umol/24h
347.0
348.2
—
5
24
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
43
342
1.26
0.74
1.0
1.0
ng/l
255.9
339.2
1.91
33
230
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
38
1.84
0.73
2.1
2.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
55
1.64
0.73
1.0
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
16
108
1.48
0.73
1.0
1.1
u/ml
0.2
2.1
1.30
11
53
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
76
1.58
0.71
1.3
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
7
40
1.75
0.71
1.1
1.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
9
57
1.58
0.71
1.0
1.1
—
5.6
—
0
11
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
26
1.92
0.70
1.2
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
35
274
1.28
0.69
1.1
1.4
titre
94.0
78.4
—
5
25
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
39
310
1.26
0.69
2.6
2.0
u/field
0.8
1.9
2.49
17
127
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
39
485
0.80
0.67
1.3
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
27
205
1.32
0.67
1.2
1.8
u/field
1.5
2.9
0.66
18
140
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
43
1.63
0.66
1.7
1.7
—
—
—
0
0
(3019174) dRVVT (LA screen)
7
43
1.63
0.66
1.1
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
28
214
1.31
0.66
1.4
1.5
mmol/l
8.6
7.9
0.44
12
124
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
22
162
1.36
0.66
1.3
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
30
232
1.29
0.66
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
26
197
1.32
0.65
3.6
2.3
e6/l
683.1
786.9
0.58
16
86
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
112
1.43
0.63
9.2
6.9
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
8
131
0.61
0.63
1.3
1.4
nmol/l
16.3
32.8
—
8
111
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
34
270
1.26
0.62
1.1
1.1
iu/ml
3.7
10.6
—
7
67
(3034274) Bile acid [Moles/volume] in Serum --fasting
48
398
1.21
0.60
2.2
2.0
umol/l
10.6
6.5
0.62
37
277
(3025577) Chromium [Mass/volume] in Blood
23
300
0.77
0.59
1.7
2.1
ug/l
1.4
2.4
1.78
18
252
(40761535) Cells panel - Urine sediment
372
3499
1.07
0.59
3.7
3.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
145
1600
0.90
0.57
1.5
1.7
mg/l
4.2
3.9
0.10
107
1120
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
74
850
0.87
0.56
1.4
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
38
1.58
0.54
1.2
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
12
82
1.46
0.54
1.2
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
30
242
1.24
0.50
1.2
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
22
171
1.29
0.49
1.2
1.1
—
—
—
0
0
(4133840)
7
107
0.65
0.48
1.6
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
298
2808
1.07
0.48
3.2
2.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
64
561
1.14
0.46
1.4
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
7
49
1.43
0.46
1.1
2.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
51
440
1.16
0.45
3.3
3.0
mg/l
194.7
32.3
0.88
37
322
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
50
1.40
0.45
1.4
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
50
1.40
0.45
1.4
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
50
1.40
0.45
1.4
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
12
86
1.40
0.44
4.1
6.9
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
31
1.61
0.43
1.6
2.3
—
—
—
0
0
(4212803)
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
32
1.56
0.42
2.6
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
12
87
1.38
0.42
1.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
376
3589
1.05
0.41
1.4
1.4
—
—
—
0
0
(3013762) Body weight Measured
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
66
586
1.13
0.41
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
71
1.41
0.39
1.3
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
10
71
1.41
0.39
1.4
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
11
80
1.38
0.38
2.9
2.4
—
—
—
0
0
(3001729) Color of Synovial fluid
5
36
1.39
0.38
1.2
1.5
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
37
1.35
0.37
1.4
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
53
468
1.13
0.36
1.4
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
90
1.33
0.35
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
13
99
1.31
0.35
1.1
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
79
717
1.10
0.35
1.5
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
950
9281
1.03
0.34
4.2
4.0
kg/l
1.0
1.0
0.23
145
1351
(3003740) Influenza virus B Ag [Presence] in Specimen
65
586
1.11
0.33
1.1
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
47
1.28
0.32
1.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
83
1.33
0.32
1.1
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1556
15319
1.02
0.31
3.1
2.9
—
—
—
0
0
(44806071)
7
53
1.32
0.30
1.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
16
129
1.24
0.30
5.9
5.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
16
129
1.24
0.30
1.1
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
55
1.27
0.30
1.0
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
73
668
1.09
0.29
1.0
1.1
u/ml
5.8
4.7
0.15
34
336
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
62
563
1.10
0.29
1.3
1.3
mmol/l
7.7
7.4
0.26
46
413
(3047007) Chlamydophila sp Ab [Presence] in Serum
65
592
1.10
0.29
1.2
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
62
681
0.91
0.29
1.4
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
52
576
0.90
0.28
1.5
1.7
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
48
432
1.11
0.27
1.0
1.1
u/ml
0.4
0.3
—
10
101
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
37
330
1.12
0.25
1.2
1.3
u/ml
0.4
1.0
0.83
19
154
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
63
684
0.92
0.24
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
63
684
0.92
0.24
1.4
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
69
746
0.92
0.24
1.5
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
63
683
0.92
0.24
1.4
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
19
162
1.17
0.22
1.3
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
11
88
1.25
0.22
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
207
2153
0.96
0.22
1.7
1.7
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
14
116
1.21
0.22
1.2
1.3
nmol/l
75.8
148.5
—
9
84
(3051593) INR in Capillary blood by Coagulation assay
22
191
1.15
0.21
13.5
8.3
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
4.1
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
1.2
—
0
10
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
653
6661
0.98
0.21
1.5
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
101
0.79
0.21
1.6
1.7
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
101
0.79
0.21
1.6
1.1
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
13103.8
—
0
5
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
26
293
0.89
0.20
1.2
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
49
1.22
0.20
12.5
8.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
144
0.83
0.19
1.9
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
99
1.21
0.19
9.1
7.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
17
197
0.86
0.19
1.1
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
26
231
1.13
0.19
1.2
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
25
222
1.13
0.19
1.0
1.0
u/ml
0.1
3.1
—
5
67
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
6
53
1.13
0.18
2.5
2.1
umol/l
27.3
46.0
—
6
46
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
555
5457
1.02
0.15
8.3
6.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
52
487
1.07
0.15
1.0
1.1
u/ml
2.0
3.9
1.35
17
189
(3008401) Mugwort IgE Ab [Units/volume] in Serum
68
644
1.06
0.15
1.0
1.1
u/ml
2.0
0.9
0.43
28
267
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
64
606
1.06
0.14
1.1
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
18
160
1.13
0.14
1.2
3.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
72
685
1.05
0.13
1.3
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
32
296
1.08
0.13
1.5
1.4
pmol/l
52.0
171.3
0.61
19
91
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
144
1395
1.03
0.13
1.6
1.9
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
21
190
1.11
0.12
1.2
1.2
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
11
127
0.87
0.12
3.7
2.6
—
152.2
—
0
21
(3003129) Base excess in Capillary blood by calculation
12
105
1.14
0.11
2.2
1.5
mmol/l
1.7
0.5
0.47
12
100
(3043238) Trisomy 21 risk [Likelihood] in Fetus
55
577
0.95
0.10
1.5
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
155
1.10
0.09
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
74
766
0.97
0.09
1.1
1.1
u/ml
1.0
1.3
0.31
26
299
(3047352) Trisomy 18 risk [Likelihood] in Fetus
54
563
0.96
0.08
1.4
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
107
1.12
0.08
1.0
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
63
607
1.04
0.08
1.0
1.1
u/ml
0.7
2.2
1.89
14
139
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
54
560
0.96
0.07
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
147
1442
1.02
0.07
1.4
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
121
0.91
0.06
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
121
0.91
0.06
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
121
0.91
0.06
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
11
121
0.91
0.06
1.2
1.1
—
—
—
0
0
(4034850)
153
1507
1.02
0.05
8.8
9.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
26
248
1.05
0.05
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
101
993
1.02
0.04
2.2
2.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
19
180
1.06
0.04
1.5
2.1
ug/l
18.6
64.2
0.55
19
167
(3014133) Dog dander IgE Ab [Units/volume] in Serum
54
529
1.02
0.03
1.0
1.1
u/ml
1.3
2.9
1.29
19
206
(3024263) Appearance of Synovial fluid
24
231
1.04
0.02
1.6
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
55
541
1.02
0.02
3.0
2.5
%
13.4
13.2
0.75
55
533
(3006462) Nitrate [Presence] in Urine
21
204
1.03
0.00
4.1
3.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
37
364
1.02
0.00
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
18
178
1.01
0.00
1.9
1.8
—
—
—
0
0
(44813793)
29
288
1.01
0.00
1.2
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
33
332
0.99
0.00
1.4
1.4
g/l
1.0
0.9
0.51
33
332
(4211845)
22
225
0.98
0.00
4.0
3.0
—
—
—
0
0
(4094501)
126
1258
1.00
0.00
1.1
1.1
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
10
96
1.04
0.00
1.0
1.3
mg/l
0.4
71.1
—
5
71
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
8
0.00
0.00
0.0
1.3
—
316.6
—
0
8
(3014171) Thiocyanate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
153.2
—
0
5
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
62
0.97
0.00
3.8
4.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
4.4
—
0
7
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
81
0.99
0.00
7.6
7.3
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
133.1
—
0
7
(3007919) Fasciola sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
66
0.91
0.00
1.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
59
0.85
0.00
1.8
1.8
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
8
86
0.93
0.00
1.0
1.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_ENDOCRINE_OTH_EXALLC – Benign neoplasm of other and unspecified endocrine glands
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).